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Introduction 
Background of tuberculosis burden in the world 
 Tuberculosis (TB) is a contagious disease mainly of the respiratory tract 
caused by Mycobacterium (M.) tuberculosis. If it is not diagnosed or well treated, a 
person with active TB can infect 10-15 other persons per year. One in three 
persons in the world is infected with M. tuberculosis. Only 5-10% of the people 
infected will be sick or infectious at any moment, in the remaining the disease 
remains latent. TB is still a global public health problem since the World Health 
Organization (WHO) declared the disease a global emergency in 1993. According to 
the WHO Report in 2008 (based on 2006 data), there were 9.2 million TB cases per 
annum of which 41% were sputum smear positive. One third of new TB cases 
occurred in the South-East Asia (SEA) Region, but the incidence in Africa was 
almost twice that in SEA as shown in figure 1.1 
 
 Figure 1. Estimated incidence of tuberculosis in 20061  
The WHO recognized 22 TB high burden countries (HBC), of which Indonesia 
ranks number three after China and India. Many of these countries have 
implemented the recommended TB control program known as DOTS strategy. DOTS 
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strategy has been applied since the 1990s and became a breakthrough in 1997 
following its success to increase the detection rate and cure-rates to nearly 80%, 
ranging from 70%-90%.2 One could expect that this would lead to conquering the 
disease but this did not happen. Nine years later, the world still had about 9 million 
new TB cases per annum; of which approximately two million died and more than 
80% of the cases occurred in the 22 HBC.3 The lack of progress was explained in 
two ways. First, DOTS strategy can only stabilize or slowly decrease the prevalence 
of TB. Secondly, new threats cause the number of TB patients still to be high even 
though the DOTS strategy has been implemented. Such threats are: (1) TB with 
HIV and (2) drug-resistant M. tuberculosis. TB is number one cause of HIV/AIDS 
deaths worldwide. HIV infection is the most important factor contributing to the 
increased incidence of TB, particularly in the African region.1 
Drug-resistant M. tuberculosis has been documented in every country. A 
particularly dangerous form is multi-drug resistant (MDR) M. tuberculosis, which is 
resistant to at least one of the first line TB drugs, isoniazid and or rifampicin, with 
or without resistance to other drugs. The MDR strain is generally treatable with 
second line drugs given for a longer period. However, mismanagement of the 
treatment and patients‟ poor compliance has lead to a new problem: the extensive 
drug resistant TB (XDR) M. tuberculosis, a strain resistant to all first and second-
line TB drugs.1,4,5  
National Tuberculosis Program in Indonesia 
The National Tuberculosis Program (NTP) in Indonesia is based on the WHO 
recommended DOTS strategy, started in 1993. The NTP is controlled by the 
government of Indonesia and integrated into the national health system.6 The head 
quarter is at the central level, under the Ministry of Health. Below this level are the 
provincial offices followed by the district offices, and at the lowest level are the 
puskesmas (primary health centres) or PPK (term for private practice at the 
primary level) who serve also the TB program.7 
In the last few years there is improvement in the case detection rate. 1 This is 
due to better promotion, more awareness, easier access and adequate service, and 
better recording at the puskesmas. Case detection rate rose from 20% in 2000 to 
12 
 
53% in 2004, but is still far from the target of 70% given by the WHO, while the 
treatment success rate has already passed the WHO target of 85%.8 
A national health and household survey in Indonesia, covering 30 provinces 
in 2004, found a prevalence rate of TB of 104/100,000 population. The survey 
showed large regional variations, in which eastern Indonesia produced the worst 
rates (Table 1).9 Diagnosis of TB in this survey was based on sputum smear 
examination confirmed by sputum culture.  
 
Table 1. Estimated TB prevalence at regional and national level in Indonesia 
2004(9)9  
 Estimation prevalence 
per 100,000 population 
National 104 
Java/Bali 59 
Outside Java-Bali 174 
 Sumatra 160 
 Eastern Indonesia 189 
 
Indonesia is still considered a country with a low HIV prevalence although 
there are some groups affected more than others, especially intravenous drug 
users. The estimated prevalence of HIV and M. tuberculosis co-infection is less than 
1%.10 Drug resistant M. tuberculosis has been reported nationwide and based on 
the country profile of the WHO Report 2006 3, the MDR TB was estimated 1.5% 
among new TB cases.  
Background of the study area  
The study was carried out in two islands, Timor and Rote islands, in Nusa 
Tenggara Timur (NTT) or East Nusa Tenggara Province. It is the most southern 
province of eastern Indonesia and among the poorest provinces of the nation. 
Formerly, it was part of the Lesser Sunda Islands, which is now divided into three 
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provinces, namely Bali, Nusa Tenggara Barat (West Nusa Tenggara) and NTT.11  
NTT consists of 566 islands, of which the four largest islands are Flores, 
Sumba, Timor and Alor. The population is 4,073,249 distributed over 15 districts, of 
which Kota Kupang - the capital of the province - is the most populated district.12,13  
The religious mix is 91% Christian (majority Catholic), 8% Muslim, 0.6% Hindu and 
Buddhist, and 0.4% holding traditional beliefs. 12  
NTT has become a refuge for Indonesian Christians who fled from the conflict 
in Maluku and Papua (former Irian Jaya). West Timor in particular has also become 
the home for refugees from East Timorese following the chaotic development after 
the independence of the country in 1999. 12  
 
Figure 2. Map of Nusa Tenggara Timur 
Besides the refugees, people from surrounding islands and also far away 
from Java and Sumatra, come to study and work in Kupang. Therefore, the city 
became the most populated area in the province and this caused people not to have 
proper housing. According to the Central Statistics Bureau (Biro Pusat Statistik - 
BPS) of NTT,13 the percentage of households living in poverty was 30.7% in 2003 
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and 28.6% in 2004, but the National Institute for Family Planning (Badan 
Koordinasi Keluarga Berencana Nasional-BKKBN) reported higher percentage of 
poor families (58.5%) in 2004.14 Different indicators were applied in both studies; 
therefore the numbers were so different. The BPS based the poverty only on the 
economic level and ability to provide food, whereas BKKBN used more complex 
indicators, i.e. the housing condition, ability to provide good food, and also ability 
to provide schooling for the children. Food security is the main problem in the 
province. All 15 districts were considered as high risk to food insecurity since they 
found high prevalence of malnutrition in under-five children, less production of rice 
than the population needs, high prevalence of poverty, poor education and more 
than 70% of total family expenditure spent only for food provision. The secondary 
school enrolment rate in NTT province was 39% and this was below the Indonesian 
average (80% in 2003/04) according to the UNESCO.15 Lack of health facilities, 
clean drinking water, and sanitation are also problems within the province and as a 
consequence, the prevalence of malnutrition in under fives (32%) and child 
mortality (71 per 1000) were higher than in most other areas in Indonesia.11  
The DOTS strategy was implemented in some areas of NTT in the mid-1990s 
but the success rates were very low, possibly because of poor training and 
supervision. After the year 2000, DOTS has gradually been expanded within the 
province, as in the rest of the country. By 2006, 201 out of 245 (82%) health 
centres and 6 out of 24 hospitals (25%) in NTT had adopted DOTS. As a 
consequence of the intensified implementation of DOTS strategy, the case detection 
rate (CDR) increased as shown in figure 3.  
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Source: Provincial health office East Nusa Tenggara. Annual health Report 2006 
 
The data show a slightly increased CDR, but the achievement in 2004 was 
still below the WHO target of 70%. The target of 70% was made based on the 
National Household Survey 2004 for eastern Indonesia and not specific for NTT. At 
the moment there are no available data of the prevalence in NTT. In 2005, the 
target was increased as a follow up after the findings of the TB prevalence for 
eastern Indonesia.9 The high prevalence of TB and low CDR are still problems in 
NTT. 
TB and malnutrition 
TB has long been considered a disease of the low socio-economic class of the 
population with certain characteristics such as low educational level, living in poor 
housing and poor sanitation, which are classified as environmental factors. Most 
individuals living in such environment also have poor health behaviour with regard 
to prevention or treatment of TB. The low socio-economic background also leads to 
Figure 3. Case Detection Rate (CDR), Conversion Rate, Cure Rate, and 
Success Rate in NTT 1999-2005 
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lack of access to the health care as well as good food that may cause the low 
immune response to tuberculosis.  
The term malnutrition has two meanings: undernutrition and excessive 
nutrition. The term malnutrition is commonly associated with undernutrition.16 In 
this thesis also the term malnutrition will be used to indicate undernutrition.  
Malnutrition may occur as an acute or as a chronic problem. Acute 
malnutrition reflects the acute imbalance between energy intake and energy 
expenditure.17 Chronic malnutrition, or chronic energy deficiency, does not reflect a 
continuous energy imbalance. Individuals with chronic energy deficiency have 
adapted to the acute energy imbalance by reducing the body energy stores and the 
body weight, observed as low body mass index, and classified as malnutrition. 
Reduced energy stores affect the function of the immune system, thus people with 
chronic malnutrition are susceptible to diseases. There is evidence that long term 
malnutrition increases morbidity and mortality and reduces the amount of working 
days. 16 
Certain people are vulnerable to long term malnutrition because nutritional 
status is influenced at individual, household, community, sub-national and national 
level (figure 4). Food insecurity may be due to a variety of causes and may lead to 
hunger in vulnerable communities and thereby individuals may become 
malnourished, who then will have a higher chance to become ill. As shown in figure 
4, the health status of individuals also affects the nutritional status because disease 
may increase the needs of energy and nutrients. Thus, disease and nutritional 
status affect each other. 
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Figure 4. Conceptual framework for understanding possible causes of low food 
consumption and poor nutritional status in a population18 
 
Malnutrition is often observed in TB patients. It is assumed that malnutrition 
causes greater susceptibility to TB through its effect on the principle host defence 
against M. tuberculosis, the cell-mediated immunity (CMI).19 Malnutrition comprises 
macro- and micronutrient deficiency. There are quite a number of studies in 
animals that describe the exact relationship between macronutrient deficiency and 
susceptibility to TB. Many of these were done in guinea pigs, as the pathogenesis in 
this animal mimics the human response to TB. 20 It has been shown in animal 
models that protein malnutrition affects the CMI, notably by reducing the number of 
T-lymphocytes.20,21,22 Also, there are studies showing the relationship between 
micronutrient deficiencies, i.e. zinc, vitamin A, and vitamin D that reduced the 
number of T-lymphocytes and its capacity to produce cytokines.23,24,25,26 
A cohort study is the most appropriate design to show the relative risk of 
macro- and micronutrient deficiency to TB, however such study is rare.19 One cohort 
study in the US, as reviewed by Cegielski et al., described the association between 
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anthropometric indicators of nutritional status and the incidence of TB. The study 
examined adult persons aged 25-74 years and nearly 95% of the participants were 
followed for almost 14 years. It was found that decrease of BMI, skinfold thickness 
or upper arm muscle increased the risk of TB six to ten fold, after controlling for 
other known risk factors for TB. In the same review, the author cited another study 
in 1940 that described the association of micronutrient deficiency, as an indicator of 
malnutrition, with TB. He described a cohort of 1058 persons free of TB based on 
radiographic criteria, which was followed for 5 years. Sixteen out of the 1058 
developed active TB and 13 among the TB patients had low concentration of 
vitamin A and C in the plasma.19 On the other hand, tuberculosis itself causes 
weight loss, protein-energy as well as micronutrient deficiency, and as a 
consequence depresses the immune system.19 A study in Sri Lanka found low BMI 
in TB patients compared to healthy controls.27 Also, a worse nutritional status was 
found in HIV infected patients with TB, compared with non-HIV infected TB 
patients, in one Singapore study.28 In Jakarta, we found lower zinc and vitamin A 
levels in TB patients compared to healthy controls.29  
Many studies showed the association between macro- and micronutrient 
deficiency with severity of TB. A previous study of our group in Jakarta found an 
association between low BMI, anaemia, low plasma retinol concentrations and high 
concentrations of IL-6 and TNF-α, both pro-inflammatory cytokines30 that induce 
anorexia and have catabolic properties.31  A study in Malawi found an association 
between micronutrient deficiencies and wasting in TB patients with HIV infection. 
The study concluded that there is a strong association between vitamin A, 
selenium, and plasma carotenoids, and the severity of wasting (BMI < 19 Kg/m2).32 
Furthermore, the study in Malawi described that the severity of the lung disease 
based on chest x-ray, was associated with low BMI and low body fat.33 The relation 
with body fat may be explained through the production of leptin. Leptin, the 26-kDa 
product of the ob-gene, is produced by adipocytes, and binds to specific receptors 
in the hypothalamus, where it suppresses appetite. Leptin may be involved in 
human TB in the cross-regulation between nutritional status and immune response. 
In Jakarta it was shown that low leptin production was common among TB patients 
as compared with healthy control, and increased after two months of treatment. 
19 
 
The study concluded that leptin production was low in concordance with low body 
fat of the TB patients, and increased as the patients gained more weight and body 
fat.34 This is in line with the Malawi study that found that leptin was not a risk factor 
for wasting among TB patients 35; however leptin might play a role in recovery of 
TB because this hormone influences the CMI.36  
Recently, more studies were published on the effectiveness of zinc and 
vitamin A supplementation against infectious diseases. Vitamin A supplementation 
was found to reduce mortality in gastroenteritis and measles, but not in acute 
respiratory infections.37 Zinc is essential to improve the immune system. A study on 
zinc supplementation found increased natural-killer cell and increased phagocyte 
activity in human infection.38 Zinc is also essential for vitamin A metabolism,39 
increases leptin production when administered to zinc-deficient patients 40 and has 
an additional advantage of stimulating appetite.41 During an intervention study of 
our group in Jakarta, it was found that combined vitamin A and zinc 
supplementation in TB patients reduced the sputum conversion time and increased 
the resolution of the active TB lesions on chest radiograph, compared to TB patients 
given placebo; both groups received regular TB treatment.42  It may be 
hypothesized that beneficial effects of micronutrient supplementation are mediated 
through improved cellular immunity and might also involved leptin.  
Statement of the problem 
A previous case-control study in Indonesia showed a poor micronutrient 
status (zinc and vitamin A) in patients with active pulmonary TB compared to 
healthy controls 29,30 and vitamin A and zinc supplementation had a beneficial effect 
in reducing the sputum conversion time.42 The questions are therefore: which of the 
micronutrient components of the previous intervention study is responsible for the 
effect, vitamin A or zinc, and what mechanism underlies the beneficial effect of the 
supplementation? 
Objectives of the thesis 
1. To assess nutritional and immune status in TB patients from a poverty area in 
Indonesia with high prevalence of TB.  
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2. To investigate whether micronutrient supplementation will improve the results of 
TB treatment. Improvement will be assessed by clinical status, sputum 
conversion time, nutritional status, immune response, changes on chest 
radiograph and laboratory tests.  
 
3. To describe the socio-demographic factors, family history of TB, and 
environmental factors associated with development of TB in NTT, one of the 
provinces with the highest TB prevalence.  
 
Outline of the thesis 
The introductory chapter one first gives background information on TB in the 
world and describes the TB control program of Indonesia. Then the interaction 
between TB and nutrition is described, followed by the objectives and outline of the 
thesis. 
 
In chapter two, we examined the question to what extent malnutrition and the 
socio-demographic factors within the NTT province might have influenced the 
susceptibility to tuberculosis. 
 
In chapter three, we looked into the determinants of TB severity based on the 
baseline characteristics of the study population in terms of clinical presentation , 
food intake and nutritional status (particularly of micronutrients), chest x-ray and 
laboratory findings. 
 
In chapter four we addressed the question whether zinc and vitamin A, either 
alone or in combination, improved the results of TB treatment. We focused on 
reduction of the sputum smear conversion time, nutritional status, chest x-ray, and 
laboratory findings as described at baseline.   
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In chapter five, we explored the question as to which are the mechanism whereby 
vitamin A or zinc supplementation improves the immune response and clinical 
status, and we studied the effect of supplementation on circulating cytokines, such 
as IL-6. 
 
In chapter six, we examined in patients receiving zinc + vitamin A, or  placebo 
supplementation, respectively, and tried to answer the questionwhether the 
supplementation increases leptin concentrations and eventually cellular immune 
function. 
 
In chapter seven, the main findings are presented and discussed. Conclusions are 
drawn with possible implications for health care and suggestions for additional 
studies in future.   
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Abstract 
Background. This study aimed to identify nutritional and socio-demographic 
factors for development of tuberculosis (TB) in Timor and Rote Island, Indonesia, 
so that intervention programmes can be developed to address these factors. 
Methods. In a case-control study, we enrolled new sputum smear-positive 
pulmonary TB patients as cases and neighbours, matched for gender and age, as 
controls. Data obtained included history of TB, socio-demographic factors and 
nutritional status. 
Results. In the study 121 TB patients and 371 controls participated. Mean age 
was 30 years, 56.3% was male and 43.7% female. Of the TB patients 87% had 
malnutrition compared to 33% among controls. Mean body mass index (BMI) of 
the patients (16.1±2.3 kg/m2) was significantly lower than that of the controls 
(19.4±3.0 kg/m2). Factors associated with the development of TB were: BMI (OR: 
0.5; 95%CI: 0.4-0.6), family history of TB (OR: 3.2; 95%CI 1.6-6.4), living in an 
extended family (OR: 2.7, 95%CI: 1.5-4.8), being non-indigenous to Timor and 
Rote Islands (OR: 2.9; 95%CI 1.2-6.8), and being unemployed (OR: 3.8; 95%CI: 
1.7-8.6). 
Conclusion. Among patients with active pulmonary TB, the prevalence of 
malnutrition was very high. Malnutrition is a general problem for the whole 
community, and especially important among the non-indigenous people to Timor 
and Rote, and should be addressed in the combat against TB. 
Keywords: tuberculosis, malnutrition, socio-demographic factors 
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Introduction 
Tuberculosis (TB) continues to be a major disease and cause of death 
worldwide. The World Health Organization, in its 2008 report, noted an increase of 
TB prevalence in the world.1 In terms of TB case load, Indonesia is still the third 
country of the world although there are some improvements of the National TB 
program.1 In 2004, a national health and household survey found that the national 
prevalence of TB was 104 per 100,000 population. The eastern provinces of 
Indonesia had the highest prevalence (189/100,000) compared to Java/Bali 
(59/100,000) or other western provinces (160/100,000).2 Of the eastern provinces, 
East Nusa Tenggara province (or Nusa Tenggara Timur (NTT)) is one of the poorest 
areas. The NTP reported achieving the target success rate of treatment in NTT, but 
there is still a problem in case detection. Therefore, it is most likely that the 
number of untreated TB patients is still high in the community (Annual report from 
the NTT Provincial Health Office, Kupang, Nusa Tenggara Timur, Indonesia 2006).  
In line with the 2nd Global Plan to Stop Tuberculosis, it is important to study 
and address associated factors that may have impact on the TB control 
programme.3 Various studies have indicated that the high prevalence of TB in 
certain areas is associated with poverty, level of education, overcrowding, 
nutritional status, and recently also with genetic susceptibility.4,5,6 However, in NTT 
until now there is no evidence  which factors are associated with the development 
of TB among the population. In addition, NTT province is also among the highest 
risk areas of childhood malnutrition, but data on nutritional status in adults are 
lacking and it is not known whether nutritional status is a risk factor for 
development of pulmonary TB in NTT Province. This study aims to assess the role of 
nutritional status and socio-demographic factors as potential risk factors for 
developing pulmonary TB in NTT Province. 
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Methodology   
Study design and study areas 
This was a case-control study as baseline part of an intervention study (in 
preparation for publication). The study was carried out in 4 districts, namely 
Kupang city, Kupang district, North Central Timor (Timor Tengah Utara, TTU) 
district and Rote-Ndao district, in Timor and Rote Island, East Nusa Tenggara 
Province, Indonesia.  
Study subjects 
Cases were newly diagnosed pulmonary TB patients registered in the NTP at 
the community health centres, aged 18-55 years. The diagnosis was based on 
sputum smear positivity for acid-fast bacilli. HIV test was not performed for TB 
patients, or for the controls. Out of 300 patients participating in the intervention 
study, 121 patients were randomly selected for the current study. For each case, 
three controls from the neighbours, with no history of TB and matched for gender 
and age, were selected. All eligible patients were informed about the study and 
signed an Informed Consent Form. Ethical clearance was provided by the Board of 
Research Ethics from the Faculty of Medicine, University of Indonesia, Jakarta. 
Data collection 
Personal interview using structured questionnaires, and assessment of 
nutritional status, were performed in all study subjects. The data obtained in the 
interview were data on socio-demographic factors and family history of TB. A 
family history of TB included: proven or suspected TB, history of TB treatment, or 
statement of cure from TB among a family member.  
Anthropometric measurements 
Body weight was assessed using an electronic platform model weighing scale 
(770 alpha; SECA, Hamburg, Germany) to the nearest 0.1 Kg. Height was recorded 
to the nearest 0.1 cm using a microtoise. Body mass index (BMI) was calculated as 
body weight divided by height squared (kg/m2). Malnutrition was categorized as 
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severe (BMI <16 Kg/m2), moderate (16-17.5 Kg/m2), mild (17.6-18.5 Kg/m2). 
Above 18.5 Kg/m2, a person would be considered as normal or overweight (BMI ≥ 
25 Kg/m2).7  
Data Analysis 
Descriptive analysis was applied to all respondents‟ characteristics, i.e. age, 
gender, level of education, occupational status and ethnic group. Differences in 
proportions were analyzed using Chi-squared test and t-test for differences in 
means. A p value < 0.05 was considered to indicate statistical significance. 
Univariate logistic regression analysis was used to assess the association between 
TB, BMI, and socio-demographic factors. Stepwise forward multiple regression 
analysis was implemented to assess whether the development of TB was 
associated with BMI and socio-demographic factors.8 
 
Results 
In the study, patients and controls from Kupang City (26%), Kupang District 
(26%), TTU (33%), and Rote-Ndao (15%) participated. Mean age of the patients 
and controls was 30 years. The number of male subjects was slightly higher than 
that of females. Most of the subjects had at least primary school education (88% 
for both patients and controls). The percentage of TB patients who did not have any 
school education was higher (7.4%) than in the control group (3.5%) although it 
was not statistically significant. Also, there was no significant difference between 
patients and controls in terms of age, gender, and ethnic group. Significant 
differences were observed between patients and controls for employment, type of 
family, body weight, BMI, the proportion of malnutrition and history of TB contact 
or suspected TB in the family (Table 1). 
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Table 1. Characteristics of respondents 
Variables Patients Control 
 n=121 n=371 
Age (mean±SD, years) 30±11.5 30.6±11.5 
Gender (n, %)   
Male 71 (58.7) 206 (55.4) 
Female 50 (41.3) 165 (44.5) 
Education (n, %) †   
No school education 9 (7.4) 13 (3.5) 
Basic education (up to 9 years) 73 (60.3) 218 (58.8) 
Higher education (> 9 years) 39 (32.2) 140 (35.7) 
Employment status (n, %) *   
Employed 55 (45.5) 230 (62) 
Not employed (including 
students, housewives) 
66 (54.5) 141 (38) 
Ethnic group (n, %)   
Indigenous Timor/Rote 103 (85.1) 323(87.1) 
Non-indigenous 18 (14.9) 48 (12.9) 
Type of family   
Number of family members (median-
IQR, person) (*)  
5 (4-9) 5 (4-7) 
Nuclear (n, %) 55 (45.5) 224 (60.4) 
Extended (n, %) 61 (50.4) 96 (25.9) 
Single/widow (n, %) 5 (4.1) 51 (13.7) 
Nutritional status   
Weight  (kg)* 40±7.8 49.1±8.6 
BMI (kg/m2)* 16.1±2.3 19.4±3.0 
    Severe malnutrition (n, %) 60 (49.6) 23 (6.2) 
    Moderate malnutrition (n, %) 22 (18.2) 26 (7.0) 
    Mild malnutrition (n, %) 23 (19.0) 75 (20.2) 
    Normal (n, %) 16 (13.2) 247 (66.6) 
Family contact with (suspected) 
TB* 
  
Yes 35 (28.9) 80 (21.6) 
No 35 (28.9) 239 (64.4) 
Do not know 51 (42.1) 52 (14) 
Family contact with person treated 
for TB (n=115)** 
  
Yes 17 (14) 22 (27.5) 
No or do not know 18 (51.4) 58 (72.6) 
Family contact with person who 
finished TB treatment / was stated 
cured (n=39)* 
  
Yes 9 (52.9) 18 (81.8) 
No 2 (11.8) 1 (4.5) 
Do not know 6 (35.3) 3 (13.6) 
Significant difference between groups was*p<0.01 and **p<0.05 and †p≈0.05 chi-squared 
for test different of proportion and t-test for different of mean. 
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In univariate logistic regression analysis, BMI, history of TB contact within the 
family, being member of an extended family, and unemployment were significantly 
associated with development of TB. BMI independently contributed to the 
development of TB. Increasing BMI of 1 Kg/m2 reduced the risk of TB by 0.5 (95% 
CI 0.4-0.6).  After sstepwise forward multiple regression analysis in the full model 
the following factors were identified contributing to development of TB: nutritional 
status (mild, moderate as well as severe), having family history of (suspected) TB, 
being non-indigenous to Timor and Rote, living in an extended family and being 
unemployed (Table 2). In particular, severe malnutrition, occurring in nearly 50% 
of the patients, came out as a major factor associated with TB (OR 36.6; CI 16.6-
80.6). 
 
Table 2. Odds ratios of nutritional status and socio-demographic factors for 
tuberculosis 
 OR (95%CI) P 
BMI 0.5 (0.4-0.6) 0.000 
Nutritional status   
Severe malnutrition 36.6 (16.6-80.6) 0.000 
Moderate malnutrition 19.6 (7.9-48.4) 0.000 
Mild malnutrition 5.5 (2.6-11.9) 0.000 
Normal  1  
   
Family history of TB   
No 1  
Yes 3.2 (1.6-6.4) 0.001 
Do not know 6.4 (3.2-12.9) 0.000 
Ethnicity   
Timorese/Rotenese 1  
Non-indigenous 2.9 (1.2-6.8) 0.000 
Family   
Nuclear family 1  
Extended family 2.7 (1.5-4.8) 0.001 
Single/widow 0.4 (0.1-1.2) 0.098 
Occupational status   
Employed 1  
Not employed 3.8 (1.7-8.6) 0.001 
Student 1.4 (0.7-3.0) 0.350 
Housewives 1.8 (0.7-4.80) 0.219 
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Discussion 
The main finding of our study was that nutritional status was an important variable 
independently associated with TB. Besides, several socio-demographic factors were 
also associated with TB in Timor and Rote islands, namely: family history of TB, 
being an extended family, being non-indigenous and being unemployed. However, 
the study has some limitations. Firstly, using a questionnaire to obtain data 
regarding family history of TB might have a recall bias and secondly, a poor 
nutritional status may be also the result of TB.  
We found that BMI had the strongest association with TB. Increase of BMI 
reduced the chance to be a TB patient. This association is probably bidirectional: 
first of all a low BMI reflecting malnutrition is a risk factor for development of TB, 9, 
10, 11 but TB in turn is known to lead to anorexia and catabolism. As found in one 
study in Ghana, high prevalence of malnutrition was reported in 51% of the TB 
patients, but they gained weight after two months of treatment.12  Malnutrition 
among TB patients in the current study (86%) was higher than in the studies in 
Ghana and Jakarta (66%). We found also that the prevalence of malnutrition 
among the controls (33%) was three times that in the Jakarta study (11%).13 It 
shows that malnutrition in adults is a serious problem in NTT. In 2005, a study 
among women of reproductive age in NTT province found that the prevalence of 
malnutrition was 19.3%, which was higher than in West Nusa Tenggara Province 
(11.1%), the neighbouring province. Furthermore, in 2006, the Ministry of Health of 
Indonesia did a national survey on food situation and food security, and classified 
NTT province as high-risk area, characterised by high numbers of poor households, 
malnutrition among children under-five, low level of education, low availability of 
rice, and low ratio of expenditure for food to total expenditure.14  
In our study, the chance of getting TB among the participants when the 
family history of TB was unclear was twice as high as when the family history was 
positive. The explanation may be that a known family history of TB leads to 
protective behaviour as shown in a study in Ethiopia, thus preventing transmission 
among family members.15 In keeping with this, we found that among participants 
who did not know the family history of TB, the risk became lower when adjusted for 
BMI, suggesting that a better nutritional state provides some protection. Therefore, 
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nutritional status, accessibility to health care, effective diagnosis, treatment and 
prevention of TB are important. Transmission of M. tuberculosis is continuing 
because of irregular or incomplete treatment, delayed diagnosis and failure to 
identify untreated patients.16, 17 
As a risk factor for developing TB, a poor nutritional status reflects the socio-
demographic context.18 Overcrowded homes and living in densely populated 
neighbourhoods are elements that contribute to the development of TB.19, 20, 21, 22  
A study in the United States on poverty and TB, between 1980 and 1990, found a 
higher risk for TB among immigrants, when adjusted for poverty. That study further 
explained that poverty was related to overcrowded living conditions that allowed 
transmission of the infection.23 On Timor and Rote islands, migrants (non-
indigenous persons) were also more prone to develop TB. The migrants came from 
surrounding small islands and also from larger islands such as Java, Sulawesi and 
Sumatra. Timor as the mainland of the province attracts more people for work or 
study, and many of them live in the crowded coast of Kupang.  
In conclusion, the prevalence of malnutrition among patients with active 
pulmonary TB is high in Timor and Rote islands. This probably contributes to 
development of active pulmonary TB, particularly among the non-indigenous 
population, living in extended families. It is recommended that the local 
government implements a malnutrition screening program based on BMI, especially 
among the migrant population. Those malnourished should be examined for TB. 
Equally so, action is required to improve the nutritional status of the population.  
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Abstract  
Background 
Plasma zinc and vitamin A concentrations have been reported to be low in 
tuberculosis (TB) patients in some studies, although it is not clear whether this 
constitutes a risk for a more severe clinical presentation among the TB patients. 
The acute phase reaction may also deplete zinc and vitamin A in plasma. Therefore 
we further studied these associations.  
Methods 
We performed a cross-sectional study among newly diagnosed sputum smear-
positive TB patients in East Nusa Tenggara. Patients were categorized as either 
mild TB when Karnofsky Score (KS) ≥ 80 or severe TB (KS < 80). Body mass index 
(BMI), mid upper arm circumference (MUAC), chest radiograph (CXR), and the 
results of haemoglobin, ESR, albumin, CRP, zinc and vitamin A in plasma were 
correlated with TB category. 
Results 
Three hundred TB patients participated in the study (63% male and 37% female), 
categorized as mild TB (53%) or severe TB (47%). Vitamin A, haemoglobin and 
plasma albumin were significantly lower, and CRP was significantly higher, in 
severe TB than in mild TB, and the active lesion area on the CXR was greater 
among severe TB patients. In a multiple regression analysis, after adjustment for 
CRP, low vitamin A (β=3.2 95%CI 1.6-4.9, p=0.000) but not zinc, correlated with 
the severity of TB. MUAC was better than BMI as predictor of TB severity (β=1.3 
95%CI 0.6-6.2, p=0.000). 
Conclusion 
Severe TB was associated with vitamin A deficiency. MUAC can be applied as a 
measure of TB severity.  
 
Keywords: vitamin A, zinc, CRP, MUAC, BMI, severity, tuberculosis  
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Introduction 
Malnutrition is a major public health problem in all developing countries 
including Indonesia. It increases susceptibility to and severity of an infection 
(Muller, 2005) and tuberculosis (TB) is a prominent example (Cegielski & 
McMurray, 2004). Malnutrition as reflected by a low body mass index (BMI) is 
common among TB patients (Metcalfe, 2005) and it increases the mortality of TB 
(Zachariah R et al., 2002). Thus, malnutrition appears to be an important 
determinant of clinical outcome of TB.  In addition to BMI, other nutritional 
indicators such as MUAC and percentage of fat are also associated with 
malnutrition. 
Apart from macronutrient deficiency, deficiency of micronutrients has been 
shown to be an important determinant of TB outcome. Two important 
micronutrients that have been studied recently in Jakarta are zinc and vitamin A. 
In this case-control study, it was found that zinc and vitamin A deficiency were 
more prevalent among  sputum smear-positive (SS+) TB patients than in matched 
healthy controls, thus contributing to the susceptibility for TB (Karyadi et al., 
2000). This conclusion is supported by in-vitro and animal studies that 
demonstrated the role of vitamin A (Villamor E, 2005) and zinc in cell-mediated 
immunity (Prasad, 1998), the important host defence mechanism against TB. 
Although micronutrients such as zinc and vitamin A may affect the immune status, 
the mechanism by which these micronutrients influence the outcome of TB is still 
unclear.  
The effects of zinc and vitamin A on the immune response lead to the 
question whether deficiency of these micronutrients poses a risk for severe TB. 
However, it is not easy to prove this notion since the acute phase response in 
inflammation causes depletion of plasma zinc (Walravens, 1979) and vitamin A in 
the form of plasma retinol (Paracha et al., 2000). In the present study we 
investigated whether severity of TB was associated with low plasma zinc and 
retinol, adjusted for CRP level, and its clinical determinants. The results may justify 
interventions with zinc and vitamin A on top of TB treatment. 
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Methods 
Study design, location and subjects 
We performed a cross-sectional study in 4 districts, covering 21 primary 
health centres (Puskesmas) and 3 district hospitals in Timor and Rote Islands, East 
Nusa Tenggara (NTT) Province, Indonesia. Subjects were newly diagnosed SS+ 
pulmonary TB out-patients who presented at the provincial hospitals or primary 
health centres. The inclusion criteria were new SS+ pulmonary TB, age 15-55 
years and not pregnant or lactating. Exclusion criteria were diabetes mellitus, heart 
disease, and accident or trauma or a surgical procedure within one month before 
inclusion into the study. HIV testing was not performed.  All eligible patients were 
informed about the study and signed an Informed Consent Form. Ethical clearance 
was provided by the Board of Research Ethics from the Faculty of Medicine, 
University of Indonesia, Jakarta.  
 
Data collection 
Personal interview and clinical examination 
Interviews using structured questionnaires were used to collect the socio-
demographic background and data on medical history. Subsequently, the patients 
were thoroughly examined by medical doctors trained for the research purpose at 
the district hospitals (WZ. Johannes, Kefamenanu and Ba‟a). Based on this 
information the Karnofsky score (KS) was calculated, ranging from 0 (dead) to 100 
(normal). Diagnosis of TB was based on three times sputum smear examinations 
(SS+) in accordance with the National TB Program guidelines from the Ministry of 
Health of the Republic of Indonesia.  
Chest X-ray examination 
Chest radiographs (CXR) were made of all patients after the diagnosis of TB 
and were evaluated by judging the visible active lesion area in both lungs. In 
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patients with cavities, the total area of exposed cavity wall was calculated from the 
radius of visible cavities ( r2) as described previously (Karyadi et al., 2000). 
Anthropometric measurements 
Body weight was assessed using an electronic platform model weighing scale 
(770 alpha; SECA, Hamburg, Germany) to the nearest 0.1 kg. Height was recorded 
to the nearest 0.1 cm using a microtoise, BMI was calculated using these data 
(kg/m2). Malnutrition was defined according to WHO criteria (available at: 
www.who.int/bmi/indek.jsp):severe malnutrition (BMI <16 Kg/m2), moderate 
malnutrition (BMI 16-16.9 Kg/m2), mild malnutrition (BMI 17-17.49 Kg/m2), normal 
(BMI 18.5-24.9 Kg/m2), overweight/obesity (BMI≥25 Kg/m2). Mid upper arm 
circumference (MUAC) was measured with a flexible in-elastic plastic measurement 
tape. Skin fold thickness was assessed at 4 sites: biceps, triceps, sub-scapular and 
supra-iliac regions, using a slim guide skin fold callipers (Creative health product, 
Plymouth, Michigan, 48170), recorded to the nearest 0.2 mm. Each site was 
measured two times on the left side of the body. The percentage of total body fat 
was based on anthropometric data, and calculated using the Durnin and Womersley 
equations (Durnin & Wormesley, 1974). 
Blood collection and analyses 
Fasting blood samples were collected between 08.00 a.m. and 10.00 a.m. in 
the district hospital. Approximately 5 mL of whole blood was taken by venipuncture 
into 5 mL vacutainers containing EDTA. Haemoglobin, erythrocyte sedimentation 
rate (ESR) and serum albumin were determined at the district hospital laboratory 
on the same day. Plasma was separated after centrifugation of blood at 750 x g for 
10 min at room temperature, and then stored at -20 C until analysis of CRP, retinol 
and zinc. Specimens were transported at a temperature of -160oC using dry ice, in 
cryoboxes to avoid direct sunlight. The cut-off points for normal haemoglobin were 
>12 g/dL and >13 g/dL for females and males, respectively. ESR was assessed 
using Westengren technique with a normal value < 20 mm/h. Serum albumin was 
measured using a spectrophotometer (Microlab 300, Merck, Germany) with a 
normal range 35-52 g/L. C-reactive protein (CRP) was measured using Enzyme-
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Linked Immuno-Sorbent Assay (ELISA) method with a normal value < 10 mg/L. 
Plasma retinol concentration was measured by HPLC (High Performance Liquid 
Chromatography), values <0.70 mol/L were regarded as indicating vitamin A 
deficiency. Plasma zinc was analyzed using Atomic Absorption Spectrometry (AAS) 
with normal values ≤10.7 mol/L (Dijkhuizen, et al. 2004). 
Food intake questionnaire 
Food intake was assessed on the basis of 24-h recall and semi-quantitative 
Food Frequency Questionnaire (FFQ) to estimate the intake of energy, protein, fat, 
carbohydrate, vitamin A, zinc, and iron. The 24-h recall was conducted on the 
weekdays. Each 24-h recall was conducted using a standardized four-stage protocol 
(Gibson, 1993). Part of the training session consisted of determining the differences 
between the amount estimated by each trainee and the actual weight of the food. 
An acceptable training level was considered when the average difference between 
the trainee's estimate and the actual food weight was  5 g. We used Nutrisurvey 
2005 © SEAMEO TROPMED RCCN, University of Indonesia, to convert the weight of 
the food into total calories, grams of fat, protein and carbohydrate and zinc and 
vitamin A intake.  
Laboratory definitions 
Vitamin A deficiency was defined as plasma retinol concentration below 0.70 
μmol/L (Saskia et al., 2002). Zinc deficiency was defined as plasma Zn 
concentration 10.7 μmol/L or below (Karyadi et al., 2000). 
Statistical analysis 
One sample Kolmogorov-Smirnov test was applied to examine normality of 
the data. For not-normally distributed variables, we examined differences of 
medians between groups using Mann-Whitney U test for significance, and 
independent student-t test to test differences between means for normally 
distributed variables (Petrie & Sabin, 2000)  We measured predictors using stepwise 
linear regression analysis (Hosmer & Lemeshow, 2000). 
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Results  
Patients were recruited between January 2004 and June 2005. Of the 497 
patients initially enrolled, 348 fulfilled the entry criteria. Reasons for exclusion of 
the 149 were age over 55 (83) or below 15 years (5), relapse (23), lactating 
mothers (11), extra-pulmonary TB (9), co-morbidity with diabetes mellitus (5), 
hepatitis (5), and other causes (8). A further 48 patients did not participate due to: 
lost to follow up (11), living in very remote area and out of the coverage area of 
the primary health centres (4), and refusing to participate (33).  
Therefore, data are presented of 300 patients. Based on Karnofsky score 
(KS), 140 (47%) out of these were classified as severe TB and 160 (53%) as mild 
TB. Most of the patients had chronic cough (98.3%) and weight loss (90.7%); 
other frequent symptoms were anorexia (65.3%), shortness of breath (45.3%) and 
haemoptysis (67%).  
Table 1 shows the clinical, laboratory and radiographic characteristics of the 
patients.  Younger patients were found significantly more often within the mild TB 
group. No difference was found for gender. Interestingly, people indigenous to 
Timor and Rote had more severe TB than the other ethnic groups. There was a 
tendency for higher degree of AFB positivity of the sputum smears in patients with 
severe TB (p=0.056). Most patients showed low body mass index, the mean BMI 
was 16 Kg/m2, sub-categorized as severe malnutrition (43.7%), moderate 
malnutrition (16.3%), mild malnutrition (23%) and normal BMI (17%). Median 
MUAC in the 300 patients was 21.2 cm (IQR 19.8-23.3 cm). Mild TB patients had 
significantly higher mean BMI‟s and MUAC‟s than those with severe TB (p=0.000).  
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Table 1. Characteristics and clinical presentation of the tuberculosis patients 
Variables 
All TB 
patients 
n=300 
Severe TB 
(KS ≤80) 
n= 160 
Mild TB 
(KS > 80) 
n=140 
p value 
Age (years)1 28 
(22-39) 
31.5 
(24-41.8) 
26 
(22-38.8) 
0.004 
Gender (%)    0.811 
Male 189(63) 89(63.6) 99(61.9)  
Female 111(37) 51(36.4) 61(38.1)  
Ethnic group (%)    0.000 
Indigenous Timor/Rote 225(75) 120(85.7) 105(65.6)  
Other 75(25) 20(14.3) 55(34.4)  
AFB positivity grade (%)    0.056 
Grade 1 89(29.7) 38(27.1) 51(31.9)  
Grade 2 91(30.3) 36(25.7) 55(34.4)  
Grade 3 120(40) 66(47.1) 54(33.8)  
Body mass index (Kg/m2)2 16 2.3 15.5±1.8 17.4±2.2 0.000 
Severe malnutrition 
(n,%) 
131 (43.7) 93 (66.4) 38 (23.8)  
Moderate malnutrition 
(n,%) 
49 (16.3) 17 (12.1) 32 (20.0)  
Mild malnutrition 
(n,%) 
69 (23) 20 (14.3) 49.930.6)  
Normal (n,%) 51 (17) 10 (7.1) 41 (25.6)  
MUAC (cm)1 21.2 
(19.8-23.3) 
20 
(18.1-22) 
22.7 
(21-24.7) 
0.000 
Percentage body fat (%)1 10.2 
(7.3-14.5) 
9.5 
(6.7-13.1) 
10.9 
(7.7-15.5) 
0.001 
Chest radiographic 
changes  
    
Active lesion area 
(cm)1 
120.5 
(60.8-197) 
174 
(100-239.4) 
92.3 
(44.4-158.6) 
0.000 
Cavity (%) 85(38.1) 55(39.3) 59(36.9) 0.718 
Cavity area (cm)1 10.7 
(4.9-18.5) 
12.6 
(7.1-24.5) 
9.6 
(4.4-15.9) 
0.374 
Haemoglobin (g/dL)2 11.3 2.5 10.8±25 11.8±2.5 0.001 
ESR (mm/hour)1 68(42.3-98) 65(40-68) 70(45-110) 0.193 
Plasma albumin (g/dL)2 3.9 0.8 3.8±0.8 4.1±0.8 0.002 
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CRP (mg/L)1 27.7 
(13.4-42.4) 
34.5 
(19.3-46.8) 
24.3 
(8.5-38.1) 
0.000 
Zinc in plasma ( mol/L)2 11.9 2.6 11.9±2.9 11.8±2.2 0.876 
Zinc deficiency (n,%) 107 (35.7) 49 (35) 58 (36.3) 0.904 
Retinol in plasma 
( mol/L)1 
0.7 
(0.5-1.1) 
0.56 
(0.39-0.88) 
0.82 
(0.58-1.22) 
0.000 
Vitamin A deficiency 
(n,%) 
149 (49.7) 90 (64.3) 59 (36.9) 0.000 
Data were expressed as 1median (IQR) and 2mean±SD. Differences were tested for 
significance using chi-squared test for proportions, Mann-Whitney U test for 
medians, and t-test for means: ap<0.001, bp<0.05 
 
The area with active lesions on chest radiographs was significantly greater in 
severe TB (p=0.000), but no significant differences were found for the presence of 
cavities and the cavity areas. Among the patients with a normal CRP, zinc 
deficiency occurred in 30.2% and vitamin A deficiency in 19%. When comparing 
mild and severe TB, there was no significant difference with regard to the 
occurrence of zinc deficiency, but vitamin A deficiency was significantly more 
frequent among patients with severe TB (p=0.000).  
We found significant correlations between BMI, MUAC, Karnofsky score, and 
plasma retinol, regardless whether CRP was elevated or not. Spearman correlation 
coefficient between BMI and retinol was 0.3 (p=0.000), and between BMI and 
Karnofsky score was 0.5 (p=0.000). Similarly, the correlation coefficient between 
MUAC and retinol was 0.3, and between MUAC and Karnofsky score was 0.5. In 
stepwise linear regression analysis age, ethnicity, MUAC, CRP and plasma retinol, 
were significant predictors of severity of TB (Table 2). BMI, gender, presence of 
cavities, and zinc status were no significant predictors.  
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Table 2. Stepwise linear regression coefficients for Karnofsky score 
Variable β 95%CI p 
Age -0.2 -0.3-0.1 0.000 
Non-indigenous* 2.8 0.6-5.1 0.015 
BMI -0.033 -0.9-0.8 0.941 
MUAC 1.3 0.6-2.0 0.000 
CRP -0.06 -0.09-0.03 0.005 
Retinol 3.2 1.6-4.9 0.000 
* compared with indigenous Timorese / Rotenese patients 
The 24-hour food recall of all patients showed lower intake than the 
recommended daily allowance for Indonesia (Table 3). The energy intake of this 
study group reached roughly one third of the recommended amount, and protein 
intake reached only approximately half of the recommendation. Regarding zinc and 
vitamin A intake, our study population consumed approximately half of the 
recommended daily allowances. Significant differences in energy intake (p=0.02), 
protein intake (p=0.007), and zinc intake (p=0.048) were found between mild TB 
and severe TB (Table 3).  
Table 3. Average daily food intake of TB patients compared to the Indonesian 
recommended daily allowances (*) 
Variables 
All TB 
patients 
Mild TB Severe TB P 
Recommended 
Daily Allowance 
Men Women 
Energy 
(kcal)† 
922.4 
(682.8-
1121.0) 
972 
(722.5-
1245.4) 
850.6 
(624.3-
1186) 
0.022 2550 1900 
Protein(g) † 26.4 
(17-40.2) 
29.2 
(20.1-
40.7) 
23.1 
(14.5-
37.2) 
0.007 60 50 
Vitamin A 
(mg) 
282 
(105-
576.5) 
299.7 
(117.6-
556) 
258 
(62.2-
598.6) 
0.463 600 500 
Zinc (mg) † 3.3 
(2.2-5.2) 
3.5 
(2.4-5.5) 
3.1 
(2.1-4.9) 
0.048 12.1 9.3 
*Recommended Daily Allowance for men and women aged 19-29 years was used according 
to the mean age of the patients in the study (28 years). 
Data were expressed as medians; between brackets P25 and P75 are given. 
†Significant 
differences were found using Mann-Whitney U test. 
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Discussion 
In this study we showed that plasma concentrations of retinol, but not zinc, 
were associated with the severity of TB, based on Karnofsky score, after 
adjustment for CRP concentration in plasma. Similar findings were found for age, 
ethnicity, and MUAC. Our findings are in line with the study in Malawi that found 
vitamin A deficiency, and not zinc deficiency, to be associated with wasting among 
TB patients, regardless of the HIV serostatus (van Lettow et al., 2004).  In that 
study, vitamin A deficiency might have been influenced by the inflammatory 
process, but inflammation markers such as CRP were not measured. Thus, vitamin 
A deficiency might have been overestimated. The inflammatory process down 
regulates protein production by the liver, such as albumin, retinol binding protein, 
and other proteins for transporting minerals, thus causing depletion of such 
vitamins and minerals. Whether vitamin A deficiency can be diagnosed in the 
presence of inflammation has been the subject of debate for a long time. 
Thurnham et al. (2003) suggested to use inflammation markers, i.e. CRP and α1-
acid glycoprotein, to classify patients as vitamin A deficient. However, categorizing 
patients based on CRP concentrations does not completely solve the problem 
because an existing vitamin A deficiency may become worse due to the 
inflammation. CRP correlates negatively with plasma retinol. In addition it makes a 
difference whether one deals with overt vitamin A deficiency (such as night 
blindness) or with subclinical vitamin A deficiency. A study among children with 
night blindness found that a classification based on CRP did not give the expected 
prevalence of vitamin A deficiency, but instead led to sampling bias (Maqsood et 
al., 2004).  The subjects in our present study, like those in the study by Thurnham 
et al. had no symptoms of vitamin A deficiency, so we only dealt with subclinical 
vitamin A deficiency. Therefore, we measured the association of low plasma retinol 
with TB severity using stepwise linear regression analysis after adjustment for CRP.  
  Active lesions on the chest x-ray in severe TB were more pronounced than in 
mild TB. Extensive active lesions are associated with a higher degree of 
inflammation in the lung (as reflected by higher CRP), which in turn may reduce 
appetite and results in decreased food intake. Both groups showed low intake of 
energy, protein, zinc, and vitamin A compared to the standard recommended daily 
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allowance for Indonesia (Table3). Thus, the low retinol concentrations in this study 
may have been a direct consequence of poor food intake, or, indirectly, a 
consequence of the chronic inflammation.  
Zinc concentrations were not different between severe and mild TB. Both 
groups showed mean concentrations above the cut-off point for zinc deficiency. This 
finding differs from that in other studies, reporting that plasma zinc concentrations 
declined during infections as a result of the acute phase response (Brown, 1998). 
Another explanation would be that plasma zinc may be transiently low, particularly 
during the acute phase of the inflammatory process, and that the homeostatic 
mechanisms restore the zinc concentration in plasma, as the plasma zinc 
represents only 0.2% of total body zinc (Brown, 1998). 
We found that BMI, percentage of the body fat and MUAC were significantly 
lower among severe TB patients, although in linear regression analysis only MUAC 
was a predictor of severity of TB. MUAC and BMI are commonly used as indicators 
of malnutrition. However, MUAC reflects a more severe condition since it also 
reflects muscle wasting. For screening in children, MUAC is an important indicator 
predicting mortality (Briend et al., 1987), but it is not commonly used for 
monitoring and follow-up of patients (Alam et al., 1989). There is an indirect 
correlation between MUAC and vitamin A deficiency. MUAC merely reflects long 
term energy and protein deficiency and this may be also associated with vitamin A 
deficiency. More importantly however, vitamin A needs fat for its absorption from 
the gastro-intestinal tract, and retinol binding protein for transportation. Thus, low 
MUAC in TB patients may be used as a better predictor of poor nutrition, and might 
indicate vitamin A deficiency; it is more reliable than BMI. 
In general, our patients presented with advanced TB, as most of them 
reported chronic cough, haemoptysis, anorexia and loss of weight. Delayed 
presentation and treatment likely caused the patients to lose appetite and become 
severely malnourished (indicated by low MUAC). Low intake of vitamin A and the 
disease itself caused low plasma retinol concentrations, and decrease of immune 
response. This in turn resulted in more severe TB.  
To summarize, our findings show that the clinical severity of tuberculosis is 
associated with low plasma retinol concentrations, but not with changes in plasma 
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zinc. Low retinol may be the consequence of both inflammation and low intake. 
MUAC is better than BMI as a predictor for severity of TB. These findings may 
contribute to the justification for nutritional and particularly vitamin A 
supplementation among TB patients.  
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Abstract 
Background 
A previous study in Jakarta showed that supplementation of zinc and vitamin A 
reduced sputum conversion time in pulmonary tuberculosis (TB) patients. In this 
study we examined the efficacy of zinc and or vitamin A, in East Nusa Tenggara 
province, Indonesia.  
Methods 
In a double blind randomized community trial, newly sputum smear positive 
pulmonary TB patients were assigned randomly to receive zinc, vitamin A, zinc + 
vitamin A or placebo. Patients were asked to deliver their sputum on weekly basis. 
Nutritional status, chest x-ray, hemoglobin, CRP, retinol and zinc level were 
examined prior to, after 2 months, and after 6 months of treatment.  
Results 
Initially, 300 patients were enrolled, and 255 complied and finished the treatment. 
Of these, only 237 had sputum samples eligible for analysis. Most patients were 
severely malnourished (mean BMI 16.5 ±2.2 Kg/m2). Patients in the zinc and 
vitamin A supplementation group showed earlier sputum conversion time (mean 1.9 
weeks) compared with that in the other intervention groups; however the difference 
was not significant in the Cox-regression model. There was a tendency that in the 
first month sputum conversion was earlier among the zinc and vitamin A 
supplementation group (HR 1.4, 95%CI 0.9-2.0), but it was not sustained after two 
months. Also, no benefit could be demonstrated of any of the used 
supplementations on other clinical, nutritional, chest x-ray, or laboratory findings. 
Conclusion 
This study among severely malnourished TB patients, did not confirm that 
combined supplementation of zinc and vitamin A significantly reduced sputum 
conversion time or had other significant benefit. Supplementation of zinc or vitamin 
A alone did not have benefit either.  
 
Keywords: tuberculosis, zinc and vitamin A supplementation, sputum conversion 
time, chest x-ray, malnutrition  
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Background  
As in other programs for the combat against tuberculosis (TB), the National 
Tuberculosis Program in Indonesia states that the disappearance of acid-fast bacilli 
(AFB) from sputum after treatment is basic in pulmonary TB patients‟ management. 
The presence of AFB in sputum can be assessed by direct visualization using the 
light microscope, and can be confirmed by growth of Mycobacterium tuberculosis in 
sputum culture. Conversion of sputum smears to AFB-negative status is only used 
in resource-limited countries (1) while in developed countries treatment success is 
measured by conversion to no growth of Mycobacterium tuberculosis in sputum 
culture. (2) The effectiveness of anti-TB therapy is determined by several factors, 
including the burden of mycobacterium, underlying immune status, adherence to 
treatment, and drug susceptibility. 
Vitamin A is a term given to a series of substances possessing specific 
biological functions. Retinol is the parent compound, which is metabolized into 
several compounds such as retinyl phosphate, retinal, and retinoic acid.(3) Vitamin 
A deficiency is common in adult pulmonary TB patients and was regarded as a 
feature of pulmonary TB.(4) A previous study in Jakarta found low plasma 
concentrations of retinol and zinc in patients with active pulmonary TB compared 
with healthy control.(5) Recently, the presence of vitamin A deficiency in sputum-
positive pulmonary TB patients compared with healthy subjects was confirmed.(6) 
 Zinc is a trace mineral, which is essential for the function of cells of the 
immune system(7), and a mild deficiency depresses the immune function in 
humans.(8) Zinc is known as an essential mineral for normal mobilization of vitamin 
A from the liver to the plasma.(9) 
The presence of micronutrient deficiencies has raised a question whether 
micronutrient supplementation would give additional benefits for the patients on top 
of the TB treatment program. In a previous clinical trial, combination of zinc and 
vitamin A supplementation resulted in earlier sputum conversion compared with 
placebo, which began as early as 2 weeks after the administration of standard anti-
TB treatment.(10) However, the efficacy of a single micronutrient supplementation, 
either zinc or vitamin A, has not been assessed. The present study was aimed to 
investigate the effect of single supplementation of zinc or vitamin A or combined 
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supplementation of zinc and vitamin A on sputum conversion time and on the 
health status of newly diagnosed active pulmonary TB patients. 
 
Methods 
Study design, time and location 
The design of the study was a double-blind, randomized community trial. 
Prior to the study, randomization was done using computer program, in which a 
treatment code was given to a subject. Patients were given standard treatment for 
TB and randomly divided into four supplementation groups: zinc alone, vitamin A 
alone, zinc + vitamin A, and placebo. The supplementation was taken daily and the 
patients were followed up until 6 months.  
The study was conducted in Nusa Tenggara Timur (NTT) Province, Indonesia, 
covering four districts in Timor and Rote Island, namely Kupang City (the capital of 
NTT), Kupang District, Timor Tengah Utara (TTU-Northern Central Timor) district 
and Rote-Ndao district, from January 2004 until December 2005. 
Subjects and sample size 
Subjects were newly diagnosed; sputum smear-positive (SS+) TB patients 
aged 15-55 years. Pregnant or lactating females were excluded and subjects who 
had underlying chronic or degenerative disease, or had surgery less than a month 
before the study, were excluded. The sample size was calculated based on the 
ability to determine a difference with = 0.05 and 1-  = 0.80 in sputum conversion 
time, clinical outcome, nutritional status (BMI), blood hemoglobin, and 
concentrations of micronutrients (retinol and zinc in plasma). As plasma retinol 
concentration was the parameter requiring the largest sample size, it was 
calculated that with a sample size of 40 in each group, a between-group difference 
of 0.12 mol/L in plasma retinol level could be detected based on the previous 
study. (10) Accounting for a 25% drop-out rate, each group in the intervention 
study comprised at least 50 subjects.  
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Micronutrient supplementation and anti-TB drugs 
Supplements and placebo were prepared by Kimia Farma Ltd, Indonesia, in 
the form of capsules. Each micronutrient capsule contained 1500 retinol equivalents 
(5000 IU) vitamin A (as retinyl acetate) and/or 15 mg zinc (as zinc sulfate) in a 
lactose matrix. The placebo capsule consisted of lactose alone. All capsules were 
similar in terms of shape, color and size. Standard TB drugs were based on WHO 
guidelines, comprising 300 mg isoniazid, 450 mg rifampicin, 1500 mg pyrazinamide 
and 750 mg ethambutol daily for 2 months, followed by 600 mg isoniazid and 450 
mg rifampicin three times each week during the next 4 months. 
Data collection 
All patients underwent physical examination, chest x-ray, nutritional and food 
intake assessment, and blood analyses before the treatment started, after the 
intensive phase, and at the end of the treatment, except for sputum examination, 
which was done weekly.  
Sputum conversion time 
During the first 2 months of the study, the patients were asked to come to the clinic 
every week to deliver their sputum for direct AFB smear examination.  Three 
specimens of early morning sputum were taken from the patients and each 
specimen was examined by direct microscopy after Ziehl-Neelsen staining in each 
Health Centre. The time was noted when the first of three weeks consecutive 
sputum smears of good quality was negative. In case either not all sputum samples 
were delivered, or if the sputum was not of adequate quality, patients were 
excluded from analysis of sputum conversion time. 
Chest x-ray examination 
Chest X-rays were performed at diagnosis on all patients and were evaluated by 
calculating the visible lesion area in both lungs. In patients with cavities, the total 
area of exposed cavity wall was calculated from the radius of visible cavities ( r2) as 
described before.(10) 
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Nutritional status 
Nutritional status was determined based on anthropometric measurements 
and micronutrient concentrations in the plasma. The anthropometrics 
measurements were: body weight, height, body mass index, skin fold thickness and 
percentage of body fat.  
Body weight was assessed using an electronic platform model weighing scale 
(770 alpha; SECA, Hamburg, Germany) to the nearest 0.1 kg. Height was recorded 
to the nearest 0.1 cm using a microtoise. Body mass index (BMI) was calculated as 
body weight divided by height squared (kg/m2). Mid upper arm circumference 
(MUAC) was measured using a flexible measurement tape. Skin fold thickness was 
measured at 4 sites: biceps, triceps, sub-scapular, and supra-iliac regions, with a 
slim guide skin fold callipers (Creative health product, Plymouth, Michigan, 48170), 
recorded to the nearest 0.2mm. The percentage   of total body fat was based on 
the skin fold data, and calculated using the Durnin and Wormesley equations.(11)  
Blood examination 
Blood samples were collected between 08.00 and 10.00 AM in the local 
health center. Approximately 15 mL of fasting whole blood was withdrawn and 
separated into 4 vacutainers (Becton Dickinson, Rutherford, NJ) containing EDTA 
and heparin. Zinc and vitamin A concentration were measured in plasma. C-reactive 
protein (CRP) was measured to adjust the micronutrient deficiency. Plasma was 
separated after centrifugation at 750 x g for 10 minutes at room temperature, and 
then stored at minus 20 C until analyzed for CRP, retinol, and zinc concentration at 
the SEAMEO-TROPMED Laboratory, Jakarta. C-reactive protein (CRP) was measured 
using enzyme-linked immunosorbent assay (ELISA) method with a normal value < 
10 mg/L. Plasma retinol concentration was measured by high performance liquid 
chromatography (HPLC), values less than 0.70 mol/L were regarded as indicating 
deficiency, and values between 0.70 mol/L and 1.4 mol/L indicates marginal 
deficiency.(12) Plasma zinc was analyzed using atomic absorption spectrometry 
(AAS) with values >10.7 mol/L regarded as normal. Determination of hemoglobin, 
WBC, and ESR were done on the same day at the provincial hospital laboratory. 
Hemoglobin and WBC were analyzed using automatic analyzer (ABX Micros 60, 
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French). The cut-off points for normal hemoglobin were >120 g/L and >130 g/L for 
females and males respectively, and ESR was assessed using Westengren technique 
with a normal value < 20 mm/h. Serum albumin was measured using 
Spectrophotometer (Microlab 300, Merck, Germany) with a normal range 35-52g/L.  
Statistical analysis 
A one-sample Kolmogorov-Smirnov test was used to determine whether the 
variables were normally distributed. Data on the characteristics of the subjects at 
enrollment for their age and gender distribution, nutritional status, blood 
concentrations, and results of radiological signs were summarized and used to 
assess the comparability of the patients randomly assigned to the four treatment 
groups. Different means between groups were tested for significance using one-way 
ANOVA when normally distributed and Kruskal-Wallis test when not-normally 
distributed. Different proportions between groups were tested using chi-squared 
test. Within group changes were tested using paired student-t test for normally 
distributed data and the Wilcoxon signed-rank when for not-normally distributed. A 
p value less than 0.05 were considered significant. Statistical analyses were 
performed using computer software SPSS for Windows PC version 14.0 (SPSS Inc, 
Chicago, IL, USA). Cox regression test was implemented to measure the effect of 
the different supplementation and association with other variables to the outcome 
of the study. All cases were included and defined as event when the AFB smear 
converted into negative and censored when failed to convert after 8 weeks, 
dropped out, or when the patient was unable to deliver sputum on weekly basis. 
Every variable was tested to fit in the Cox-model, a cut off for p value 0.25 was 
implemented as the screening criteria for the model building.(13) 
Ethical considerations 
This study adhered to the Council for International Organizations of Medical 
Sciences guidelines (CIOMS, 1991). Data were collected after subjects agreed to 
participate in the study and gave written informed consent voluntarily. The 
research proposal was approved by the Ethics Committee of the Faculty of 
Medicine, University of Indonesia. 
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Results 
A total of 300 patients were enrolled into the study and randomly grouped 
into 4 categories of intervention, i.e. supplementation of zinc (n=76), vitamin A 
(n=72), combined zinc + vitamin A (n=66) and placebo (n=86). After two and six 
months some patients were withdrawn from the study, so that a total of 255 
patients completed the study (Figure 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Reasons for patients‟ drop out during the study. After two months 274 
patients were still in the study, while 255 patients completed the study after 6 
months. 
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Patients‟ mean age was 31.5 years and approximately 63% of them were 
men. Mean BMI for the four groups varied from 16.4 – 16.6 and was 16.5 for all 
300 patients combined, indicating severe malnutrition. The mean value of MUAC 
and percentage body fat were extremely low. Sputum positivity grade 3 was most 
prevalent. The prevalence of cavities on chest X-ray was almost 40% for all groups. 
These findings suggested that the patients had severe TB. There was no difference 
of baseline characteristics among the 4 groups of patients except for the proportion 
of patients with cavities (Table 1).  
In total 237 patients delivered all required sputum samples and of good 
quality. As shown in Table 2, mean sputum conversion time of the zinc + vitamin A 
intervention group was the shortest, and that of the zinc intervention group the 
longest. The differences in conversion time between the zinc group and both, the 
vitamin A and the vitamin A + zinc group, were statistically significant. After one 
week, sputum was smear negative in 58.5% of patients from the zinc + vitamin A 
group, in 45.6% of patients in the vitamin A and placebo groups,  whereas the zinc 
group showed the lowest percentage (35.3%). After two months no significant 
differences were found between the groups (Figure 2). Taken into account the 
WHO success rate target of 85% conversion to negative, we observed that patients 
in the zinc + vitamin A supplementation group reached the target within 4 weeks, 
similar to the vitamin A group, followed by placebo group (5 weeks), and zinc group 
(6.6 weeks). We developed two Cox regression models: after the first month of 
treatment and after 8 weeks of treatment.  
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Table 1.  Baseline characteristics of TB patients (n=300)  
Variables 
Groups 
Zinc 
(n=76) 
Vitamin A 
(n=72) 
Vitamin A + Zinc 
(n=66) 
Placebo 
(n=86) 
Age (year) , mean+ SD 30.9±11.8 33.1±11.5 30.1±12 31.4±10.4 
Gender:     
 Male 51 (67.1) 46 (63.9) 42 (63.6) 50 (58.1) 
 Female 25 (32.9) 26 (36.1) 24 (36.4) 36 (41.9) 
Sputum smear grade:     
 + 1   18 (23.7) 22 (30.6) 25 (37.9) 24 (27.9) 
 + 2 24 (31.6) 19 (26.4) 18 (27.3) 30 (34.9) 
 + 3 34 (44.7) 31 (43) 23 (34.8) 32 (37.2) 
     
BMI (kg/m2)  16.5 ± 2.2 16.5± 2.2 16.6 ± 2.1 16.4 ± 2.5 
MUAC (cm) 21.1 (19.8-23.1) 21 (20-23) 21.3(20-23.6) 21.8(19-23.6) 
Body fat (%) 11±4.5 11±6.2 10.8±4.7 11.9±5.9 
Radiology signs:      
 No. with cavities* 18 (25.7) 35 (51.5) 25 (38.5) 36 (41.9) 
 Cavity area (cm2) 10.2 (4.9-17.4) 12.0 (6.2-22.1) 12.9 (4.8-15.9) 10.2 (4.9-21.6) 
 Total lesion area 
(cm2) 
120 (71-179.8) 139 (44-216) 143 (73-198) 129 (62-209) 
Plasma CRP (mg/L) 25.7 (13.7-38.8) 27.9 (11.5-42.1) 29.1 (12.6-43.0) 30.9 (13.3-47.4) 
Serum albumin (g/L)   38.3 ± 8.4 39.9 ± 7.5 40.2 ±9.6 38.4 ± 8.3 
Leukocytes (cells/mm3)  9300 (7575-13000) 9750 (7775-11575) 10200 (7475-12250) 9750 (7000-2225) 
ESR (mm)  73.0 (48.0-99.5) 59.5 (40.0-88.5) 62.0 (36.0-92.0) 75.0 (42.0-109.0) 
Hemoglobin (g/dL)  11.2 ± 2.7 11.6 ± 2.4 11.6 ± 2.5 11.0 ± 2.5 
Plasma zinc (µmol/L)  11.6 ± 2.2 11.9 ± 3 12.1 ± 3.0 11.8 ± 2.4 
Plasma retinol (µmol/L) 0.7(0.5-1.0) 0.7(0.5-1.5) 0.7(0.4-1.1) 0.7 (0.5-1) 
* chi-squared test, p <0.05 
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Table 2. Parameters after two months of treatment (n=274)1 
Variables Groups 
 Zinc 
(n=69) 
Vitamin A 
(n=66) 
Zinc+ Vit A 
(n=57) 
Placebo 
(n=82) 
Sputum conversion time (wk) 1ab 3.02 ± 2.2ab 2.1 ± 1.6a 1.94 ± 1.4b 2.5 ± 1.7 
Duration of WHO target 
achievement (wk)‡ 
6.6 4.0 4.0 5.0 
     
BMI (kg/m2) 17.7 ± 2.33 17.8 ± 2.23 17.7  ± 2.03 17.5 ± 2.43 
MUAC (cm) 1 23 (21-25) 3 22 (20.1-24.7) 3 23 (21-24) 3 23 (20.8-24.5) 3 
Body fat (%) 12.9±5.03 13.3±5.93 12.9±5.13 14.2±6.13 
Radiology signs     
 No. with cavities (n.%)2c 5 (7.5) 17 (27) 8 (14.8) 13 (17.1) 
 Cavity area (cm2) 6.2 (2.5-21)3 5.5 (2.5-13.7)3 5.9 (2-16.2) 3 4 (3.1-10)3 
 Total lesion (cm2)  40.5 (12-100)3 35 (0-80)3 37 (9-94.5) 3 32.5 (4.5-77.5)3 
Plasma CRP (mg/L) 4.6 (1.4-13.8)3 4 (1-14.3)3 4.2 (1.3-15.5) 3 6.4 (1.5-14.6)3 
Serum albumin (g/L) 44.6 ± 6.8 43.2 ± 8.8 43.5 ± 7.4 43.8 ± 7.8 
Leukocytes (cells/mm3) 6700 (5400-8100)3 6600 (5600-8050)3 7500 (5500-8875)3 7300 (5900-9100) 
ESR (mm) 28 (16-40)3 31 (18-40)3 30 (17.3-38.8)3 28 (16-45)3 
Hemoglobin (g/dL) 12.5 ± 2.783 12.6 ± 2.553 13.18 ± 2.483 12.12 ± 2.433 
Plasma zinc (µmol/L) 11.7 ± 2.43 11.6 ± 1.83 12.5 ± 2.33 11.7 ± 2.33 
Plasma retinol (µmol/L) 1.2 (1-1.6)2a,3 1.5(1-2)2ab,3 1.3 (1-1.9)3 1.2 (0.9-1.6)2b,3 
1 Data are expressed as mean ± SD or median (IQR), †number of good quality sputum analyzed for zinc, vitamin A, 
zn + vitamin A and placebo groups were: 62, 57, 50, and 68 respectively (total 237). ‡ WHO target: 85% subjects 
converted into SS negative.  
2  Significant difference between groups p < 0.05 (One-way ANOVA), post hoc test: a,b Least Significant Difference p 
< 0.05, c Chi-squared test p < 0.05 
3 Significant changes within group from the baseline p < 0.001 (paired student-t test) 
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Figure 2. Cumulative percentage of the sputum conversion time. The zinc + 
vitamin A (n=50) and vitamin A groups (n=56) showed less weeks to reach 85% of 
sputum conversion, followed by the placebo group (n=62). The zinc 
supplementation group (n=68) showed the longest time to reach 85% of sputum 
conversion. 
 
At 4 weeks of treatment (Table 3A), zinc + vitamin A supplementation 
showed higher HR 1.4 (95%CI 0.9-2.0) than after completion of the intensive 
phase of TB treatment: HR 1.1 (95%CI 0.7-1.1; Table 3B). However, the overall 
sputum conversion time showed no significant difference between different 
supplementation after adjustment for age, ethnic group, AFB level, hemoglobin 
concentration and plasma retinol concentration at the baseline (Table 3A and 3B). 
After 2 months of treatment, there were significant improvements of micronutrient 
status within groups compared with the initial levels, particularly in patients given 
combined vitamin A and zinc supplementation or placebo (Table 2). The proportion 
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of cavities on chest x-ray was significantly different between the four groups 
(Table 2) but not after 6 months of treatment (Table 4). The changes of the 
proportions between groups however, were not significant. At the end of treatment, 
significant changes from the baseline were observed for all variables except for zinc 
concentration in the group receiving vitamin A and the group receiving zinc + 
vitamin A, but no difference between groups was observed (Table 4). 
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Table 3A. Cox regression results for predicting sputum conversion time after 4 
weeks of treatment1  
Predictor variable HR 95% CI p 
    
Supplementation vs. placebo 
(adjusted)* 
   
Zinc 1.1 0.7-1.6 NS 
Vitamin A 1.2 0.8-1.7 NS 
Zinc + vitamin A 1.4 0.9-2.0 NS 
    
Ethnic group of indigenous Timor-Rote 1.5 1.0-2.1 0.031 
AFB level compared to +1    
+3 0.7 0.5-1.03 0.078 
Plasma retinol at baseline** 1.3 1.0-1.6 0.031 
1 All eligible results (n=237) were classified as events when converted positive and censored 
when remained negative after 4 weeks of treatment. Patients who did not provide good 
quality of sputum, or were lost to follow up, were considered as censored cases in the 
model.  
* All significant variables were put in the model. 
** adjusted for concentration of CRP at baseline. 
 
Table 3B. Cox regression results for predicting sputum conversion time after 
intensive phase (8 weeks of treatment)1  
Predictor variable HR 95% CI P 
    
Supplementation vs. placebo 
(adjusted)* 
   
Zinc 1.0 0.7-1.4 NS 
Vitamin A 1.1 0.8-1.7 NS 
Zinc + vitamin A 1.1 0.8-1.9 NS 
    
Ethnic group of indigenous Timor-Rote 1.5 1.1-2.0 0.013 
AFB level compared to +1    
+3 0.7 0.5-1.0 0.040 
Plasma retinol at baseline** 1.3 1.1-1.6 0.008 
1 All eligible results (n=237) were classified as events when converted positive and censored 
when remained positive after 8 weeks. Patients who did not provide good quality of sputum, 
or were lost to follow up, were considered as censored.  
* All significant variables were put in the model; CRP was included in the model for 
adjustment of plasma retinol and hemoglobin level.  
** adjusted for concentration of CRP at baseline. 
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Table 4. Parameters after six months of treatment (n=255)1 
Variables Groups 
 Zinc 
(n=63) 
Vitamin A 
(n=59) 
Zinc+ Vit A 
(n=56) 
Placebo 
(n=77) 
     
BMI (kg/m2) 18.5±2.22 18.1±2.42 18.3±2.02 18.4±2.62 
Increasing BMI from the 
baseline (kg/m2) 
1.9±1.3 1.7±1.6 1.9±1.5 2.0±1.4 
MUAC (cm)  24 (22.5-25.1) 2 23.0 (21.8-25.0)3 24.0 (22.0-25.3) 2 24 (22.5-26) 2 
Body fat (%) 14.5±5.82 14.2±6.42 14.2±6.42 16.0±6.32 
Radiology signs     
 No. with cavities (n.%) 5 (8.1) 3 (5.3) 2 (3.6) 3 (4.2) 
 Total lesion (cm2)  0 (0-42.4) 3 0 (0-25.8) 2 0 (0-21) 2 0 (0-25.8) 2 
Plasma CRP (mg/L) 1.3 (0.5-2.7) 2 1.5(0.6-3.3) 2 1.1 (0.5-4.4) 2 1.7 (0.9-402 
Serum albumin (g/L) 4.6±0.52 4.6±0.72 4.7±0.62 4.6±0.52 
Leukocytes (cells/mm3) 6000 (5100-7000) 2 6900 (5275-8100) 
2 
6800 (5850-7800) 
2 
6800 (5800-8100) 
2 
ESR (mm) 11 (4-28) 2 14 (8-28.8) 2 12 (6-28) 2 11 (8-28) 2 
Hemoglobin (g/dL) 12.8±2.3 2 13.0±2.2 2 13.3±2.2 2 12.8±2.3 2 
Plasma zinc (µmol/L) 13.1±1.92 12.5±2.1 12.8±2.9 12.6±1.7 3 
Plasma retinol (µmol/L) 1.4 (1.1-1.9) 2 1.6 (1.2-2.0) 2 1.6 (1.2-1.9) 2 1.4 (1.0-1.8) 2 
1 Data are expressed as mean ± SD or median (IQR) 
Significant changes within group from the baseline 2p < 0.001 (paired student-t test) and 3p<0.05 
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Discussion 
In this double-blind randomized community trial, supplementation with zinc 
and vitamin A, either alone or combined, failed to show superiority over placebo in 
a Cox Regression model, despite the finding of a difference in sputum conversion 
time between the four treatment groups. This is unexpected, as we could not 
confirm the results of the previous study in Jakarta, in which vitamin A and zinc 
supplementation was beneficial in terms of sputum conversion.(10) Another finding 
was that the sputum conversion time was associated with level of plasma retinol 
adjusted for CRP, AFB positivity grade at baseline, and ethnicity.  
Results similar to ours with regard to zinc supplementation were obtained in 
a study in Tanzania (14), where such supplementation did not lead to a reduction of 
sputum conversion time compared to supplementation with a multi-micronutrient or 
placebo either.  Also, zinc supplementation did not improve immune response 
among TB patients infected with HIV in a study in Singapore.(15) The authors 
further concluded that in the absence of zinc deficiency, additional zinc 
supplementation was not beneficial. To the best of our knowledge, the data on the 
effect of vitamin A supplementation in TB were inconclusive. (16-18)  
How can we explain the discrepancy between the results of the Jakarta study 
and the current results?  The first explanation might be found in retinol 
concentrations and inflammatory response at baseline. In Jakarta study, higher 
mean retinol concentrations (0.8µmol/L and 0.9µmol/L for the supplemented and 
placebo groups, respectively) were found than in the current study (0.7 µmol/L for 
all groups).(10) The mean baseline CRP concentrations in the Jakarta study 
(53mg/L for the micronutrient group and 44.1 for the placebo group) were almost 
twice as high as in the current study (mean CRP for all groups=28.4mg/L). Higher 
CRP concentrations reflect a stronger inflammatory response, which is known to 
lower the plasma retinol concentrations.(19) Thus the patients in the Jakarta study 
may have had a lesser degree of vitamin A deficiency, inflammation leading to the 
low plasma retinol levels.  This might imply that higher dosages   of vitamin A 
supplementation would have been needed for the TB patients of the current study 
to reach retinol concentrations necessary for a clinical effect. With regard to zinc 
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deficiency, the same may apply although in both studies the mean zinc 
concentrations are borderline and similar.    
The second explanation may be connected to the differences in the chest 
radiographs and the grading of sputum AFB positivity. A study in New York in 1997 
found that predictors of sputum conversion time were HIV status, history of 
tuberculosis, presence of cavities on chest x-ray, and number of acid-fast bacilli in 
the sputum smear.(20) The number of patients with cavities in our study was 
similar (38%) to that in the Jakarta study (37.5% of total patients in both group). 
More important however, is that in the present study, the proportion of patients 
with cavities among the four groups differed significantly at baseline (Table 1), 
with the highest proportion of cavities (51.5%) being present in the patients of the 
vitamin A supplementation group. This disbalance may have obscured the effect of 
vitamin A supplementation but would not explain the lack of effect in the zinc + 
vitamin A group.  The severity of TB in our patients is witnessed by the fact that 
40% had sputum AFB positivity grade 3 prior to treatment whereas in the Jakarta 
study 68% had grade 1 (for both supplemented and placebo groups) and this can 
be expected to lead to longer sputum conversion time.(20) It may be that the 
supplementation effect does not become clear in such severe cases.   
Another explanation may be related to the observation that the patients in 
the current study were more malnourished than the patients in the Jakarta study. 
Mean BMI of our cohort was 16.5 Kg/m2 as compared to 18.5 Kg/m2 in the Jakarta 
study.(10) Such a low BMI may reflect two processes. One would be protein energy 
malnutrition (which severely affects host defense) and the other wasting due to the 
catabolism induced by the acute phase response.(21-22) Neither of these is directly 
affected by supplementation of micronutrients and hence it may not be remarkable 
that we failed to show an effect in this study.   
The final explanation for the difference between the two studies may be that 
our study population has an ethnic background different from the patients in the 
Jakarta study. Whereas in the Jakarta study, the patients were mainly from Java, 
Sunda and Sumatra, with a minority of others, the current study consists mainly of 
patients indigenous to Timor and Rote islands.(23) One finding in our study was 
that ethnicity was associated with sputum conversion time. In line with this, a 
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recent study showed that vitamin D receptor genetic polymorphisms were 
associated with the time to sputum culture conversion.(24) Also it was shown that 
vitamin D receptor genotype independently predicted the sputum smear 
conversion time while on anti-TB therapy.(25) One might speculate that ethnic 
background also plays a role in the response to supplementation with 
micronutrients.    
We conclude that the patient groups studied here, were suffering from severe 
tuberculosis with cavities in at least one third of the patients, and high sputum 
positivity grade. The patients were deficient in vitamin A and zinc and perhaps 
more important, also severely malnourished. Against this background we were not 
able to replicate the results of the Jakarta study that demonstrated a beneficial 
effect of vitamin A and zinc in tuberculosis. This means that the previous findings 
cannot be generalized. Therefore there is no basis for routine administration of such 
supplements to patients with TB. 
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Abstract 
Background  Zinc and vitamin A supplementation has been shown to be beneficial 
as an adjunct to standard anti mycobacterial treatment in Indonesia. However, the 
mechanism by which micronutrient supplementation improves treatment outcome is 
not understood. The present study was aimed at finding the effects of zinc and 
vitamin A supplementation on cytokines of active pulmonary tuberculosis (TB). 
Methods Two community-based, double-blind placebo controlled trials were carried 
out in two provinces in Indonesia: Jakarta and Nusa Tenggara Timur (NTT). In the 
Jakarta study, TB patients were given standard TB treatment and were randomized 
to a 6 month supplementation with zinc + vitamin A vs. placebo; while in NTT, 
patients were randomized into four groups: zinc, vitamin A, zinc + vitamin A and 
placebo. Circulating concentrations of IL-6 and ex vivo production of IL-1β, TNF-α, 
IL-6, IL-1ra and IFN-  after incubation with and without stimulation were measured 
by specific immunoassays.  
Results  In Jakarta, 40 supplemented patients and 40 patients given placebo were 
studied while in NTT, 76 patients receiving zinc, 72 on vitamin A, 66  on zinc + 
vitamin A and 86 on placebo supplementation were included. After 2 months of 
treatment (but not after 6 months), there were significant reductions of circulating 
IL-6 concentrations and ex-vivo LPS-stimulated IL-6 production between patients 
supplemented with zinc + vitamin A and those receiving placebo in the Jakarta 
study. The LPS-induced ex-vivo production of IL-1β, TNF-α and IL-1RA, which was 
elevated at baseline, significantly decreased during treatment but did not differ 
between the groups. PPD-induced IFNγ production increased over the treatment 
period, but again to the same extent in both treatment arms. In NTT, a similar 
decrease in circulating IL-6 was seen, however the rate of decrease did not differ 
between the treatment arms. 
Conclusions In both trials, TB treatment led to a decrease in inflammatory 
markers. Combined zinc and vitamin A supplementation appeared to induce a 
stronger reduction of IL-6 concentrations in Jakarta compared with placebo, but 
these findings could not be replicated in the subsequent study in NTT.   
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Introduction 
Tuberculosis (TB) is a highly prevalent serious infection in developing 
countries. The prevalence in Indonesia is among the highest in the world, with 
prevalence of 253 patients per 100,000 populations.(1)  
Although antimycobacterial treatment meets with a high success rate 
(>85%), it is not without problems: the treatment takes at least 6 months, side 
effects of treatment are not uncommon, and resistance towards the first-line 
antimycobacterial drugs is increasing.(1) For these reasons new approaches 
towards treatment are being looked for. Within that context our group has been 
investigating whether micronutrient supplementation benefits patients with TB in 
Indonesia. We have previously published that supplementation of zinc plus vitamin 
A was beneficial as an adjunct to standard anti-TB treatment.(2) However, the 
mechanism by which such micronutrient supplementation improves treatment 
outcome was not elucidated.  In a group of 41 untreated tuberculosis patients and 
matched healthy controls, we could show that plasma concentrations of interleukin-
6 (IL-6) and interleukin-1 receptor antagonist (IL-1ra) were significantly higher 
than in controls.(3) These findings are in accordance with the literature, in which 
elevated pro-inflammatory cytokines were found in untreated TB.(3,4,5)  
In our study, higher IL-6 concentrations were especially seen in patients with 
pulmonary cavities, and in those with a low body mass index (<18.5 kg/m2).(6) We 
also found that zinc deficiency was associated with high lipopolysaccharide (LPS)-
stimulated production of tumor necrosis factor-alpha (TNF-α) and of IL-1ra. Plasma 
retinol concentrations were correlated with concentrations of IL-6 after LPS 
stimulation. From these data the question emerged to what extent cytokine 
concentrations in active TB would be modulated by antimycobacterial treatment and 
by micronutrient supplementation. We investigated this question in two prospective 
randomized controlled clinical trials in tuberculosis in Jakarta and in East Nusa 
Tenggara (NTT) province, respectively.  
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Methodology 
Patients 
The study was carried at two sites in Indonesia, in Jakarta and subsequently 
in NTT province. TB patients in Jakarta were enrolled at the pulmonary clinic at one 
general hospital and three primary health centers (Puskesmas) in Central Jakarta, 
whereas TB patients in NTT were enrolled at three general hospitals and 22 
Puskesmas in Timor and Rote Islands. The Jakarta study was done between 
December 1997 and December 1998, the study in NTT between January 2004 and 
July 2005. Inclusion criteria for the patients were age 15-55 years and diagnosed 
as new pulmonary TB based on three sputum specimens positive for acid-fast bacilli 
(AFB) by direct microscopy and graded as positive 1, 2 and 3. Exclusion criteria 
were: medical history of TB, extra-pulmonary TB, injury or operative procedure one 
month before enrollment, known diabetes mellitus or having elevated fasting blood 
glucose, and clinical evidence of neoplasm or congestive heart failure. Female 
patients were excluded when lactating or pregnant. Testing for HIV was not done 
because Indonesia has a low prevalence of HIV-TB co-infections. All patients 
participating in the study were followed-up for 6 months.  
Study design 
Both studies were community-based, double-blind placebo controlled trials. 
In the Jakarta group, eligible TB patients were assigned randomly to 
supplementation with zinc + vitamin A or placebo. In NTT, patients randomly 
assigned to supplementation with either zinc, vitamin A, zinc + vitamin A, or 
placebo.  
TB drugs and micronutrient supplementation 
Short course standard TB drugs were provided by the Indonesian 
government through the National Tuberculosis Program (NTP), consisting of 300mg 
isoniazid, 450 mg rifampicin, 1500 mg pyrazinamide and 750 mg ethambutol, taken 
daily for 2 months, followed by 600mg isoniazid and 450 mg rifampicin three times 
a week for the next 4 months. The micronutrients and placebo capsules were 
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prepared by Kimia Farma Ltd, Indonesia in coded packages. The capsule contained 
either 5000 IU vitamin A or 15 mg zinc (in a form of zinc sulfate) alone or both, in a 
lactose mix, while the placebo capsule consisted of lactose only. The supplement 
and the placebo were similar in their appearance and were taken daily up till 6 
months after the start of treatment. Intake was supervised by the TB patients‟ 
partner called pengawas minum obat (PMO).  
Data collection 
Assessment of clinical status 
Evaluation of the clinical status was done by the first authors and medical 
doctors trained for the research purpose. Clinical assessment included physical 
examination, Karnofsky score, weight and height. Karnofsky score ranged from 0 
(dead) to 100 (normal). Body mass index (BMI) was calculated as body weight (kg) 
divided by squared height (m) and classified as malnutrition if <18.5 Kg/m2. The 
CXR‟s were evaluated by a radiologist for presence of cavity, cavity surface area, 
and total active lesion area. The total lesion area was determined by measuring the 
visible abnormality in both lungs in cm2. The cavity surface area was calculated by 
measuring the diameter and assuming the cavity to be round.  
Blood sampling 
Fasting blood samples were taken via venipuncture and divided into two 
vacutainers, one with EDTA and one with heparin as anticoagulant. The EDTA blood 
was used for measuring hemoglobin, white blood cell count, albumin, and 
erythrocyte sedimentation rate. The heparin blood was centrifuged at 3000 rpm for 
15 minutes. The plasma was frozen at -80oC, in an Eppendorf vial containing 1.5 
mL to measure C-reactive protein (CRP), zinc, and retinol.  
Nutritional status 
Nutritional status was determined by anthropometric measurements and 
micronutrient concentration in plasma. The anthropometric measurements were: 
weight, height, skinfold thickness, BMI and percentage of body fat.  
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Body weight was assessed using an electronic platform model weighing scale 
(770 alpha; SECA, Hamburg, Germany) to the nearest 0.1 kg. Height was recorded 
to the nearest 0.1 cm using a microtoise.   
Micronutrient status was determined by measuring zinc and vitamin A 
concentration in plasma. C-reactive protein (CRP) was measured to correlate the 
micronutrient deficiency with degree of inflammation. Plasma was separated after 
centrifugation at 750 x g for 10 minutes at room temperature, and then stored at 
minus 20oC to be analyzed later for CRP, retinol, and zinc concentration at the 
SEAMEO-TROPMED Laboratory, Jakarta. CRP was measured using enzyme-linked 
immunosorbent assay (ELISA) with normal values < 10 mg/L. Retinol was 
measured by high performance liquid chromatography (HPLC) and were categorized 
into three subgroups, severe vitamin A deficiency (< 0.70 μmol/L), moderate 
deficiency (0.70 – 1.05 μmol/L), and no deficiency (> 1.05 μmol/L). Plasma zinc 
was analyzed using atomic absorption spectrometry (AAS) with values >10.7 
μmol/L regarded as normal. 
Cytokine measurements 
Five 2-mL blood samples were collected in sterile vacutainer tubes containing 
lithium heparin (Becton Dickinson, Leiden, The Netherlands) for the measurement 
of cytokines, both circulating and after incubation.  
The first tube was centrifuged at 2250 x 6 for 10 min and the supernatant 
was centrifuged at 15,000 rpm for 5 min. Aliquots were stored at -20oC until assay 
of cytokines. To the blood in four other tubes were added 50μL of phosphate-
buffered saline solution containing one of the following: lipopolysaccharide (LPS, E. 
coli serotype 0.55:b5, Sigma, Zwijndrecht, The Netherlands; final concentration 
10ng/L); phytohaemagglutinin (PHA-P, Sigma, St. Louis, USA; final concentration 
10μg/L); bovine tuberculin PPD (ID-DLO, Lelystad, The Netherlands; final 
concentration 10 μg/L) and nothing (blank). The tubes were incubated at 37oC: the 
LPS, PHA, and blank tubes for 6 hours and the bovine tuberculin tube for 24 hours. 
After incubation, all tubes were centrifuged and handled as the first tube.  
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Concentrations of IL-1β, TNF-α and IL-1ra after incubation with and without 
stimulation were measured in duplicate by specific radioimmunoassay, with 
sensitivity of 40, 40, and 80 pg/mL, respectively. Concentrations of IL-6 and IFN-γ, 
both circulating and after stimulation, were measured by enzyme-linked 
immunosorbent assay (ELISA) according to the guidelines of the manufacturer 
(Pelikine, Sanquin, Amsterdam, The Netherlands). The detection limit for both IL-6 
and IFN-γ was 3pg/mL.  
Statistical analysis 
The data were tested using one-sample Kolmogorov-Smirnov test to 
determine normal distribution. Paired t-test was used to test a difference within 
groups with normal distribution and Wilcoxon signed-rank test for not-normally 
distributed data. One-way ANOVA test was used to test differences between groups 
with normally distributed data and Kruskall-Wallis for not-normally distributed data.  
Results 
Of the 80 patients recruited in Jakarta 40 received supplements with zinc + 
vitamin A and 40 patients were given placebo. In NTT, 300 patients were 
randomized to receive either zinc (n=76), vitamin A (n=72), zinc + vitamin A 
(n=66) or placebo (n=86). Two-hundred and nine patients in NTT finished 
treatment and were included in the analysis. The characteristics of the patients of 
both studies are given in Table 1. There was no significant difference of baseline 
characteristics between the groups in the Jakarta study, or between those in NTT. 
However, there was a tendency of lower body weight, BMI, and Karnofsky score 
among patients in NTT, compared to those in Jakarta. 
Of the circulating cytokine concentrations measured in the Jakarta study, 
only those of IL-6 were detectable. During anti-TB treatment, circulating IL-6 
concentrations decreased about 2-4 fold. After 2 months of treatment circulating 
IL-6 concentrations were significantly lower in patients given zinc + vitamin A 
supplementation than in patients given placebo (ANOVA; p< 0.05); at 6 months 
such differences were not present anymore (Figure 1A). 
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The unstimulated ex-vivo production of IL-1β, IL-6, TNF-α, IFN-  and IL-1RA 
after 24 h incubation was low and did not change during treatment; it was not 
affected by micronutrient supplementation (data not shown). When the cells were 
exposed to LPS, marked production of IL-1β, IL-6, TNF-α, IFN-  and IL-1RA was 
seen (Figure 1B-E). The production IL-6, IL-1β, and IL-1RA decreased during anti-
TB treatment (p<0.05) but did not differ between the micronutrient intervention 
group and the placebo group, with the exception of IL-6 production. The latter was 
significantly lower in patients given zinc + vitamin A supplementation than in 
patients given placebo at 2 months of treatment (ANOVA; p< 0.05); at 6 months 
such difference was not present anymore (Figure IB). In contrast, PPD-induced 
production of IFN-   increased during treatment (p=0.001), but again was not 
affected by the supplementation (Figure 1F). 
Next, we explored the effect of either zinc or vitamin A supplementation and 
of the combination in NTT. Despite the fact that the groups were well matched, the 
baseline serum IL-6 concentration was higher in the vitamin A and placebo groups 
than in both other groups; however these differences were not significant (ANOVA, 
p=0.293). In all groups again, there was a more than 5-fold decrease of IL-6 
concentrations, but the rate of decline was not significantly different between the 
groups (ANOVA, p=0.491; Figure 2B).  
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Table 1. Characteristics of the patients at both study sites 
Characteristics Jakarta study Nusa Tenggara Timur study 
Zn+vit A Placebo Zn Vit A Zinc+VitA Placebo 
n = 40 n = 40 n =55 n =48 n =51 n =55 
Age (year)* 26.1±7.3 29.6±9.9 28.6±9.7 32.2±11.7 29.5±11.9 29.6±9.3 
Male/female (%) 25/15 24/16 37/18 32/16 31/20 34/21 
Body weight (Kg)* 44.7±5 43.6±6.2 42.1±7.0 41.2±6.3 41.2±7.0 42.9±8.1 
Body mass index <18.5 
Kg/m2 (%) 
25 (63) 26 (65) 41 (85) 42 (87.5) 42 (84) 43 (78.2) 
Temperature (oC) 37.3±0.8 37±0.6 37.1±0.8 37.2±1.0 37.2±0.8 37.1±1.0 
Karnofsky score* 80.8±3.5 82±4.6 77.3±3.3 74.4±9.2 74.9±6.4 75.6±12.7 
Sputum smear grade (%)       
+ 25 (63) 29 (73) 14 (25.5) 15 (31.3) 18 (35.3) 14 (25.5) 
++ 11 (27) 9 (220 18 (32.7) 12 (25) 14 (27.5) 23 (41.8) 
+++ 4 (10) 2 (5) 23 (41.8) 21 (43.8) 19 (37.3) 18 (32.7) 
Abnormalities of the CXR       
Infiltration (%) 40 (100) 40 (100) 55 (100) 48 (100) 51 (100) 55 (100) 
Cavity (%) 17 (42) 13 (32) 12 (21.8) 23 (47.9) 20 (39.2) 23 (41.8) 
Mean surface area of the 
cavity (cm2)* 
25.4±20.1 17.3±12.4 12.6±11.3 14.3±10.7 11.5±8.5 16.2±13.7 
Mean lesion area (cm2)* 233.9±138.5 221.3±120.7 140.2±90.1 155.5±104.4 132.8±83.6 146.8±103.6 
Plasma CRP (mg/L)* 53±31.8 44.1±36.5 33.3±32.9 32.2±24.3 37.2±32.2 38.4±37 
Zinc (µmol/L)*       
0 month 11.52±0.26 11.15±0.28 11.3 ± 2.2 12.2 ± 2.9 12.0 ± 3.1 11.9±2.7 
2 month 11.22±0.38 10.22±0.363 11.7 ± 2.0 12.4 ± 2.2 12.4 ± 2.2† 11.6±2.4† 
6 month 12.50±0.352 12.13±0.312 13.0 ± 1.71 12.3 ± 2.3 12.8 ± 3.0 12.5±1.8 
Retinol (µmol/L)        
0 month 0.82±0.04* 0.90±0.04* 0.7 (0.5-0.8)** 0.7 (0.5-1.2)** 0.7(0.5-1)** 0.7 (0.4-1) ** 
2 month 1.14±0.051* 1.08±0.042* 1.3 (0.9-1.7)1** 1.4 (1-1.9)1** 1.3 (0.9-1.8)1** 1.1 (0.9-1.7)1** 
6 month 1.39±0.061†* 1.27±0.051†* 1.3 (1.1-1.8)1** 1.5(1.1-1.9)1** 1.5 (1.1-1.8)1** 1.3 (1.1-1.7)1** 
Data were expressed as *mean ± standard deviation or **median (interquartile range). No significant difference was observed 
at baseline for both Jakarta and NTT study.  
1,2,3 significant within group changes from baseline, 1p<0.001, 2p<0.01 and 3p<0.05(paired t-test) Significant difference for 
plasma retinol between zinc + vitamin A supplementation group and placebo† in Jakarta study in change from baseline 
(p<0.05, one-way ANOVA), and in NTT study for plasma zinc after 2 months (p=0.009; one-way ANOVA). 
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C-reactive protein concentrations sharply fell in all subgroups after 2 months 
of treatment and remained low (p= 0.000). The decrease in CRP was not 
significantly different between the four treatment groups (Figure 2A). The fall in 
CRP was paralleled by a decrease in circulating IL-6. 
Zinc concentrations of the four groups in NTT (Table 1) were not different 
initially prior to treatment (mean 11.8±2.7 µmol/L for all groups) and considered as 
normal concentrations. After six months of supplementation there were no 
significant changes of zinc concentrations within groups (mean 12.7±2.2 µmol/L for 
all groups) except for the zinc supplemented group (11.3±2.2 at baseline, 13.0 ± 
1.7µmol/L after 6 months, paired t-test, p<0.001). No difference between groups 
was observed. The retinol concentrations in NTT indicated moderate vitamin A 
deficiency (median for all groups 0.7 µmol/L) and increased significantly for all 
groups to almost twice the baseline value after two and six months of 
supplementation (median for all groups 1.3 µmol/L, Wilcoxon signed rank test, p= 
0.000).  Again, no significant difference between groups was observed.  
 
Discussion 
The present paper reports the results of cytokine studies of two subsequent 
micronutrient supplementation RCTs in TB patients, performed in Jakarta and NTT, 
Indonesia. In the first study, the circulating IL-6 concentrations showed a faster 
decrease in the group of TB patients that received a vitamin A plus zinc supplement 
than in the placebo control group. This decrease was also found in the ex-vivo LPS-
stimulated IL-6 production, but not in the production capacity for other cytokines. 
The results for IL-6 parallel the earlier sputum smear conversion and radiological 
resolution in the intervention group.(2) 
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A. IL-6 (circulating; pg/ml)   B. IL-6 (LPS ex-vivo stimulated; pg/ml)  
 
 
 
C. TNF-α (LPS ex-vivo stimulated; pg/ml)  D. IL-1β (LPS stimulated ex-vivo; pg/ml) 
 
 
E. IL-1ra (LPS stimulated ex-vivo; pg/ml) F. IFN-γ (PPD stimulated; pg/ml) 
 
 
Figure 1. Mean changes of cytokine concentrations in Jakarta patients after TB 
treatment and supplementation with zinc + vitamin A or placebo, respectively. 
Data are expressed as mean, n=40 (unless specified). *Significant difference of 
mean circulating and LPS ex-vivo stimulated IL-6 after two months of treatment 
(ANOVA p<0.05). 
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Figure 2. Results of (A) CRP and (B) IL-6 concentrations prior to, at 2 and 6 
months of treatment in NTT study groups. No significant difference at the 
baseline for both parameters. Significant changes from baseline were observed 
for both CRP and IL-6 concentrations (paired t-test, *p<0.001, and **p<0.01). 
No significant difference of the changes from baseline between the four groups.   
 
A 
B 
  
* * * 
* 
* * * * 
* * 
** 
** ** 
** 
* * 
 89 
The 4-arm study in NTT, however, did not confirm these results. Although 
circulating IL-6 concentrations also strongly decreased during antimycobacterial 
treatment, here, the decline in circulating IL-6 was not different between the 
treatment arms. It should be noted that in this study, the beneficial clinical effect of 
micronutrient supplementation observed in Jakarta was not confirmed (Pakasi et 
al., submitted). Even the group with the combined vitamin A and zinc supplement 
did not fare better than the other arms. 
The divergent results between the Jakarta and the NTT study have puzzled 
us a lot, and there is no easy explanation. First of all, both studies were performed 
using the same methodology (including laboratory investigations). The supplements 
used were of the same quality and made by the same factory. Although we do not 
have proof, we do not have reasons to assume that the patient compliance in NTT 
was different from that in Jakarta. 
One major difference between the two studies is the fact that the patients in 
NTT were more severely affected with lower BMI, lower Karnofsky scores and a 
higher proportion of grade 3 sputum positivity. With regard to zinc status at 
baseline the data in both trials did not differ (Table 1), and there was no evidence 
of zinc deficiency.(2) Mean plasma retinol concentrations were slightly higher in 
Jakarta group than in the NTT trial (Table 1) with ≈30% of the former patients 
having plasma retinol concentrations below 0.7µmol/L. Although in NTT about 50% 
of patients had plasma retinol concentrations below 0.7μmol/L, one could argue 
that still macronutrient malnutrition was more prominent in NTT, and that 
overshadowed the effect of the micronutrient supplementation.    
Despite the lack of an effect of the interventions in the second study, both 
studies show that treatment with anti-TB drugs meets with a decrease in 
inflammatory response as demonstrated by the circulating concentrations of IL-6 
and the ex-vivo production of IL-6 and TNFα. These findings are in accordance with 
those from Sahiratmadja et al. in Jakarta.(7) Also the anti-inflammatory response 
as measured by the production of IL-1Ra decreased during this period. Most 
intriguing is the low production of PPD-induced IFNγ production at the start of 
treatment, which also was restored during treatment. This finding corroborates that 
of the mentioned study from Jakarta,(7) and since IFNγ is considered the most 
 90 
important effector cytokine in tuberculosis, it points to defective host defense 
against M.tuberculosis before treatment. The fact that our first intervention study, 
in which the zinc + vitamin A supplementations appeared to be effective, did not 
show a different IFNγ response is a strong argument that the supplement does not 
work through this effector pathway. 
To conclude, combined zinc and vitamin A supplementation appeared to 
induce a stronger reduction of IL-6 concentrations in Jakarta, but these findings 
could not be replicated in the subsequent study in NTT. The different results might 
be attributed to a more severe condition of the patients in the NTT study. In 
addition, it is possible that the micronutrient supplementations do not work through 
the cytokine network.   
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Abstract 
Background. Increase of leptin might contribute to the recovery of pulmonary 
tuberculosis (TB). Zinc might induce leptin production, and zinc + vitamin A 
supplementation has been found to reduce sputum conversion time and fasten 
recovery of the chest x-ray (CXR) in TB patients. The aim of the study was to find 
whether zinc + vitamin A supplementation increased leptin concentrations and was 
associated with inflammatory markers and clinical outcome. 
Method. A double-blind, placebo-controlled community-based intervention study 
was performed in East Nusa Tenggara Province, Indonesia. Eligible patients with 
TB were assigned randomly to supplementation with zinc + vitamin A or placebo, 
in addition to standard anti-TB treatment. 
Results:  At baseline, leptin concentrations in the zinc + vitamin A supplementation 
group (n=48) and the placebo group (n=50) were very low. These levels increased 
equally in both groups, to approximately twice the baseline level during anti-TB 
treatment. Women had higher leptin levels than men at baseline, and after 2 and 6 
month of treatment (p<0.000). Log-transformed leptin concentrations correlated 
inversely with CRP. There was also a correlation with the percentage of body fat, 
prominently among female patients at baseline, and after 2 and 6 months of 
treatment.   
Conclusion. The rise in leptin concentrations during anti-TB treatment correlates 
with the decrease in inflammation and with the increase of  body fat. 
Supplementation with zinc + vitamin A did not affect leptin concentrations.  
Keywords: tuberculosis, inflammation, leptin, zinc, vitamin A 
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Introduction 
Leptin is a 16-kD protein that inhibits food intake and increases energy 
expenditure, thereby regulating body fat stores.(1) During acute inflammation, 
plasma leptin concentrations increase, induced by bacterial lipopolysaccharide(2) 
and by cytokines, such as tumor necrosis factor-alpha (TNF-α), interleukin-1 beta 
(Il-1β), and leukemia inhibitory factor.(3,4,5,6,7) During chronic inflammatory 
diseases, such as tuberculosis (TB), however, leptin concentrations tend to be low, 
as was found in studies in Jakarta(8) and Malawi(9). The plasma leptin 
concentrations in the two studies did not correlate with weight loss (wasting) and 
anorexia. In the Jakarta study, it was found that tuberculosis patients with low body 
fat had low leptin concentrations, which inversely correlated with CRP and TNF-α 
production. Thus, it was hypothesized that loss of body fat and prolonged 
inflammation suppressed leptin production. The study by Schwenk et al confirmed 
that leptin concentrations do not correlate with wasting, but these investigators 
could not demonstrate that leptin concentrations correlated with the 
proinflammatory cytokine response.(10)  
The role of leptin in tuberculosis has been assessed in an animal model using 
the leptin-deficient ob/ob mice(11) and also has been shown in human study.(12) 
The findings in the leptin-deficient mice suggest an important role for leptin in the 
immune response to MTB, as indicated by a reduced production of interferon-
gamma and delayed type IV hypersensitivity reaction after injection with 
Mycobacterium tuberculosis (MTB). In the human study, leptin was shown to have 
an impact on the elimination of MTB and also to the recovery of the lung as shown 
in the chest x-ray.(12)  
In a previous study from our group in Jakarta, zinc and vitamin A 
supplementation reduced the sputum conversion time and accelerated recovery of 
the lung in pulmonary TB.(13) Zinc is a mineral which is known to increase appetite 
(14), to enhance cell-mediated immunity, and to have an anti-inflammatory 
function(15), while vitamin A is known to increase the cellular immune response 
and maintain the integrity of epithelial tissues.(16) In animal studies, zinc 
deficiency reduces leptin concentrations(17,18), whereas supplementation of zinc 
increases leptin production through the regulation of appetite.(19,20)  
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The present study aimed to investigate whether zinc + vitamin A 
supplementation, compared to placebo, as an addition to anti-TB treatment 
increased leptin concentrations and whether the increase was associated with 
clinical outcome of patients with pulmonary TB. 
 
Methods 
Study design, time and location 
The study was a double-blind, placebo-controlled, community-based 
intervention study. Prior to the study, randomization was done using computer 
program, in which a treatment code was given to each patient. Patients received 
standard treatment for TB and were randomly divided into four supplementation 
groups: zinc alone, vitamin A alone, zinc + vitamin A, and placebo. The 
supplementation was taken daily and the patients were followed up until 6 months. 
For financial reasons, we measured leptin concentrations only in the zinc + vitamin 
A supplementation group and the placebo group. Thus, only results are presented 
about these two groups. 
The study was conducted from January 2004 until December 2005 in Nusa 
Tenggara Timur Province, Indonesia, covering four districts in Timor and Rote 
Islands, namely Kupang City (the capital of NTT), Kupang District, Timor Tengah 
Utara (TTU-northern middle Timor) district and Rote-Ndao district. 
Subjects and sample size 
Subjects were newly diagnosed pulmonary TB sputum smear-positive (SS+) 
patients aged 15-55 years old. Female subjects should not be pregnant or lactating. 
Subjects who had other underlying disease, or had surgery a month before the 
study started were excluded. The sample size was calculated based on the ability to 
determine a difference with α= 0.05 and 1-β = 0.80 in nutritional status (BMI), and 
concentrations of micronutrients (retinol and zinc in plasma). As plasma retinol 
concentration was the parameter requiring the largest sample size, it was 
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calculated that with a sample size of 40 in each group, a between-group difference 
of 0.12 µmol/L in plasma retinol level could be detected.(13)  
Micronutrient supplementation and anti-tuberculosis drugs 
Supplements and placebo were prepared by Kimia Farma Ltd., Indonesia, in 
the form of capsules. Each micronutrient capsule contained 1500 retinol equivalents 
(5000 IU) vitamin A (as retinyl acetate) and 15 mg zinc (as zinc sulfate) in a 
lactose matrix. The placebo capsule consisted of lactose alone. Standard TB drugs 
were given based on WHO guidelines: 300 mg isoniazid, 450 mg rifampicin, 1500 
mg pyrazinamide and 750 mg ethambutol taken daily for 2 months, followed by 
600 mg isoniazid and 450 mg rifampicin three times each week during the next 4 
months. 
Data collection 
All patients underwent physical examination, chest x-ray (CXR), nutritional 
and food intake assessment, and blood analyses before the TB treatment started, 
after the intensive phase of treatment (i.e. after 2 months), and after completion of 
treatment (i.e. after 6 months).  
Chest x-ray examination 
Chest X-rays were evaluated by calculating the visible lesion area in both 
lungs. In patients with cavities, the total area of exposed cavity wall was calculated 
from the radius of visible cavities (r2) as described before.(13) 
Blood examination 
Fasting blood samples were collected between 8 and 10 a.m. in the local 
health center. Approximately 15 mL of fasting whole blood was drawn and 
separated into four vacutainers (Becton Dickinson, Rutherford, NJ): two containing 
EDTA and two containing heparin. Determination of hemoglobin was done in the 
same day at the provincial hospital laboratory, using automatic analyzer (ABX 
Micros 60, French). Plasma was separated after centrifugation at 750 x g for 10 
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minutes at room temperature, and then stored at minus 20C until analysis. C-
reactive protein (CRP) was measured using enzyme-linked immunosorbent assay 
(ELISA) method with a normal value < 10 mg/L. The leptin status was determined 
by measuring its concentration in plasma, using ELISA from R&D systems, Duoset 
human leptins. 
Nutritional status 
Nutritional status was determined by anthropometric measurements (weight, 
height, skinfold thickness, body mass index and percentage of body fat), and by 
measuring the concentrations of the micronutrients zinc and retinol in plasma.(21)  
Body weight was assessed using an electronic platform model weighing scale 
(770 alpha; SECA, Hamburg, Germany) to the nearest 0.1 kg. Height was recorded 
to the nearest 0.1 cm using a microtoise. Body mass index (BMI) was calculated as 
body weight divided by height squared (kg/m2).  
In plasma samples, prepared as described above, retinol concentration was 
measured by high performance liquid chromatography and values less than 
0.70µmol/L (20μg/dL) were regarded as low retinol concentration based on the 
International Vitamin A Consultative Group definition. 1 Plasma zinc was measured 
using atomic absorption spectrometry with values >10.7 µmol/L regarded as 
normal concentration. 
Statistical analysis 
One-sample Kolmogorov-Smirnov test was used to examine whether the 
variables were normally distributed. Data on the characteristics of the subjects at 
enrollment for their age and gender distributions, nutritional status, blood 
examinations, Karnofsky score, and results of radiological signs were summarized 
and used to assess the comparability of the patients assigned to the four treatment 
groups. Within group changes were tested using paired student-t test for normally 
distributed data and the Wilcoxon signed-rank for the not-normally distributed data. 
A p value less than 0.05 was considered significant.  Multivariate regression models 
were used to assess predictors of leptin at baseline, and after 2 and 6 months of 
treatment. For this reason, we used log-transformed leptin concentrations as an 
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outcome variable. The same method was applied for the other not-normally 
distributed variables in the model. Stepwise backward analysis was implemented 
using probability of F-test < 0.5 to include in the modeling. Least sum of squares 
test was used to select best models.  Statistical analyses were performed using 
computer software SPSS for Windows PC version 14.0 (SPSS Inc, Chicago, IL, 
USA). 
Ethical considerations 
The study adhered to the Council for International Organizations of Medical 
Sciences guidelines (CIOMS, 1991). Data were collected after subjects agreed to 
participate in the study and gave written informed consent voluntarily. All data on 
subjects were kept strictly confidential. Subjects who suffered from complications 
related to side effects of the standard anti-TB therapy or who contracted other 
diseases were withdrawn from the study and referred to hospital for further medical 
treatment. The research proposal was approved by the Ethics Committee of the 
Faculty of Medicine, University of Indonesia. 
Results 
A total of 98 cases were included, 48 cases in the zinc + vitamin A 
intervention group and 50 in the placebo group. The mean age of all patients was 
29 years with no significant differences between the two groups (Table 1). Male 
patients represented 61.2% of the study population and 71.4% of patients was 
indigenous to Timor and Rote Islands. Very low BMI and percentage of body fat 
were seen in all patients. No significant differences were noted in baseline 
characteristics between the two groups. 
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Table 1. Characteristics of the patients  
Variables Zn+Vit A Placebo 
p 
n=48 n=50 
Age (year)1 29±1.7 29±1.4 0.836 
Gender   0.838 
 Male  30(62.5%) 30(60%)  
 Female  18(37.5%) 20(40%)  
Ethnic groups   0.825 
 Indigenous Timor-Rote  35(72.9%) 35(70%)  
 Non-indigenous Timor-Rote  13(27.1%) 15(30%)  
AFB positivity grade    0.218 
 +1 18(37.5%) 12(24%)  
 +2 13(27.1%) 21(42%)  
 +3 17(35.4%) 17(34%)  
Karnofsky score2 70 
(70-80) 
70 
(70-82.5) 
0.777 
 Mild TB  23(47.9%) 29(58%)  
 Severe TB  25(52.1%) 21(42%)  
Body weight (kg)1 41.1±1.0 43.2±1.1 0.183 
Body mass index (kg/m2) 1 16.5±0.3 16.7±0.4 0.724 
MUAC (cm)1 21.5±0.3 22±0.5 0.442 
Percentage of body fat (%)1 10.7±0.7 12.2±1.0 0.207 
Cavity size (cm2)2 10.9 
(4.3-16.3) 
10.2 
(6-20.6) 
0.667 
Lesion area in the CXR (cm2)2 143 
(74-195) 
120.5 
(58.9-211) 
1,000 
Hemoglobin (g/dL)1 11.4±2.7 11.0±2.8 0.540 
CRP (mg/L)2 29.4 
(17.2-
45.8) 
30.8 
(12.4-
46.5) 
0.706 
Retinol (μmol/L)1 0.8±0.4 0.8±0.4 0.785 
Zinc (μmol/L)1 12.2±3.1 11.9±2.7 0.642 
          Data were expressed as 1mean ± SD or 2median (IQR)  
          CXR: chest X-ray 
 
In both groups there was a significant increase of BMI and percentage of 
body fat after two months of treatment; at the end of therapy the BMI of the 
patients had increased some 2 Kg/m2 (Table 2). In both arms, retinol 
concentrations approximately doubled during treatment (p<0.000). Zinc 
concentrations however, did not significantly change during the first two months of 
treatment and tended to rise after two months. A significant and dramatic reduction 
of C-reactive protein levels was seen at two months and six months of therapy, 
reflecting the effectiveness of therapy in reducing inflammatory response. Low 
concentrations of leptin were found in all patients at the beginning of the study 
 101 
(Table 2); these concentrations approximately doubled after two and six months 
of treatment (p<0.05). However, there were no significant differences for any of 
these parameters between the zinc + vitamin A supplementation and placebo 
groups (Table 2). No correlations were observed between plasma zinc or retinol 
concentrations and leptin concentrations. 
 
Table 2. Changes in nutritional parameters, chest X-ray, micronutrients and 
plasma leptin before, during and after TB treatment in both intervention groups 
 
Variables Zinc + Vitamin A Placebo P 
BMI (kg/m2)1    
 0 month 16.5±2.0 16.7±2.7 0.724 
 2 month 17.6±2.0a* 17.6±2.5a* 0.864 
 6 month 18.4±2.1a*,† 18.8±2.7a*,† 0.404 
Body fat (%)1    
 0 month 10.7±4.8 12.1±6.7 0.207 
 2 month 13.0±5.4a* 14.2±6.7a* 0.301 
 6 month 14.7±6.8a*,b† 16.3±7.1a*,† 0.249 
Cavity size (cm2) 2    
 0 month 10.9 (4.3-16,3) 10.2 (6-20.6) 0.667 
 2 month 0 (0-0) a* 0 (0-0) a* 0.497 
 6 month 0 (0-0) a* 0 (0-0) a* 0.543 
Lesion area (cm2) 2    
 0 month 143 (74-195) 120.5 (159.8-211.0) 1.000 
 2 month 37 (13.3-95) a* 37 (11.5-96) a* 0.897 
 6 month 0 (0-2) a* 0 (0-27.9) a* 0.959 
Zinc (μmol/L) 1    
 0 month 12.2±3.1 11.9±2.7 0.642 
 2 month 12.4±2.2 11.5±2.4 0.077 
 6 month 12.9±2.9 12.5±1.8b† 0.336 
Retinol (μmol/L) 1    
 0 month 0.7±0.4 0.8±0.4 0.785 
 2 month 1.4±0.6a* 1.3±0.6a* 0.667 
 6 month 1.7±1.1a* 1.5±0.7a*,† 0.358 
CRP (mg/L) 2    
 0 month 29.4 (17.2-45.8) 30.8 (12.4-46.5) 0.726 
 2 month 4.6 (1.4-15.7)a* 6.7 (1.7-17.6)a* 0.826 
 6 month 1.8 (0.5-7.6)a*,c† 1.7 (0.8-3.5)a*,† 0.394 
Leptin (ng/mL) 1    
 0 month 2.1±0.5 3.1±0.7 0.245 
 2 month 4.0±5c* 4.4±0.9b* 0.724 
 6 month 5.7±1.1c* 6.0±1.2c*,d† 0.891 
Data were expressed as 1mean±SD or 2median (IQR) 
Within group changes from baseline* and 2nd month†, were tested using Wilcoxon Signed 
Rank test for not normally distributed data and paired t-test for normal distribution:  
ap<0.000, bp<0.01, cp<0.05, d tendency to be significant (p≈0.05).  
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Log-transformed leptin concentrations in men were significantly lower than in 
women (Figure 1), both at baseline, and after two and six months of treatment 
(independent t-test, p< 0.000).  The increase in leptin concentrations was more 
pronounced in female patients than in male patients. The rate of reduction in mean 
CRP concentrations (Figure 2) did not differ between males and females. However, 
female patients achieved normal CRP level (<10mg/L) significantly earlier than 
male patients, after two months of treatment.  
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Figure 1. Mean log-transformed leptin concentrations in male and female TB patients. 
Significant differences between males and females were found before and after 2 and 6 
months of treatment (independent t-test, p<0.000)  
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Figure 2. Mean plasma CRP concentrations in male and female patients during anti-
TB treatment. No significant difference was found at baseline. Mean CRP levels in 
female patients were significantly lower than those in male patients after 2 months 
of treatment *(Mann-Whitney U, p=0.012) and tended to be lower at the end of 
treatment (Mann-Whitney U, p = 0.099). 
 
Leptin concentrations correlated with CRP level at two and six months of 
treatment after log-transformation for both variables (Table 3). Log-transformed 
leptin concentrations also correlated with the log-transformed active lesion area of 
CXR before treatment (r=-0.4, p=0.001) and after 2 months (r=-0.3, p=-0.3) of 
Time of measur ment (months) 
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treatment. BMI and percentage of body fat at all three measurement points were 
correlated with log-transformed leptin concentrations as well, however in multiple 
linear regression analysis, the percentage of body fat appeared to be a predictor 
and was more pronounced in females after 2 and 6 months of treatment (Table 3). 
At baseline, a strong correlation was found with active lesion areas in the lungs 
after log-transformation but not with CRP level, regardless of gender. After two 
months of treatment, log-transformed leptin concentrations correlated significantly 
with log-transformed CRP level but not after 6 months when adjusted for other 
variables.  
 
Table 3. Regression coefficient (β) of various variables with log [plasma leptin] 
Months Variable β Standardized β 
95% CI 
P 
LL UL 
0 Percent body fat 0.047 0.617 0.03 0.6 0.000 
 Log [active lesion on the 
chest x-ray] 
-0.351 -0.254 -0.3 -0.068 0.009 
2 Female 0.34 0.34 0.1 0.6 0.002 
 Percent body fat 0.04 0.43 0.02 0.05 0.000 
 Log [plasma CRP at 2 
months of treatment] 
-0.22 -0.27 -0.3 -0.09 0.001 
6 Female  0.3 0.136 0.17 0.56 0.038 
 Percent body fat 0.04 0.504 0.02 0.06 0.000 
 Log [plasma CRP at 6 
months of treatment] 
-0.12 -0.14 -0.3 0.02 0.093 
Dependent variables are log-transformed leptin concentrations before treatment (0 months), after 2 
and 6 months of treatment.  LL = lower limit and UL = upper limit of the confidence interval.  
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Discussion 
In this double blind placebo-controlled trial of zinc + vitamin A 
supplementation during treatment of pulmonary TB in Indonesia, we found that 
leptin concentrations, which were initially very low, increased during anti-TB 
treatment. There was a clear gender effect in which females gained more body fat 
and produced more leptin than males. In addition, leptin levels rose while the 
inflammatory parameters decreased. Contrary to our expectations, the rise in leptin 
did not correlate with the concentrations of zinc and or retinol in plasma, and did 
not differ between the group receiving zinc + vitamin A supplementation and that 
receiving placebo.  
The explanation for this unexpected finding is probably that anti-TB 
treatment leads to a strong reduction in inflammatory response and this effect has 
an overriding impact on leptin regulation. This is in accordance with our finding of 
negative correlation of both log-transformed CRP level and log-transformed active 
lesion area on CXR, with leptin concentrations. The findings are in line with two 
other studies. In the previous study in Jakarta, it was hypothesized that prolonged 
inflammation down regulates leptin production, as the study also found negative 
correlation between CRP and log-transformed leptin among TB patients.(8) 
Likewise, a negative correlation was found between leptin and CRP levels in 
rheumatoid arthritis patients, also fitting with the notion that inflammatory 
mediators may cause wasting and loss of body fat, and this loss in turn may reduce 
leptin production.(23) 
The possible effect of zinc supplementation on leptin concentrations stems 
from a study in 1998, reporting that serum leptin concentrations were decreased 
after a 6-month period of zinc depletion in male volunteers and restored after zinc 
repletion.(24) A trial in healthy American Indian subjects in Paraguay failed to show 
an increase of leptin concentrations after zinc supplementation. It was concluded 
that the absence of zinc deficiency before the intervention might have been the 
reason.(25) Although our study population was malnourished, more than two thirds 
of the patients did not exhibit true zinc deficiency since the mean value (about 12 
μmol/L) was above the cut-off point (10.7 μmol/L). Approximately one-third of 
patients (31.6%) had zinc concentrations below the cut-off point which might be 
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due to inflammation. No difference in leptin response was observed between 
patients with zinc deficiency and those without (data not shown). Likewise, a true 
deficiency of retinol was not present, and this may explain why the subjects did not 
show a clear response after supplementation.    
An additional finding from the present study was that the amount of body fat 
correlates with the leptin level at baseline, and at 2 and 6 months of treatment, 
particularly among women. This is consistent with the finding in a longitudinal study 
of TB by Schwenk et al., of significant increases leptin concentrations and body fat 
after TB treatment.(10) We found that women gained significantly more body fat 
than men during TB treatment and this may explain at least in part the significantly 
higher leptin concentrations in the females, fitting with the concept that the initial 
low leptin concentrations are the result of low body fat and that restoring body fat 
after TB treatment increases leptin concentrations.(8) 
In conclusion, we confirmed that TB patients in Indonesia have low plasma 
leptin concentrations. Treatment of TB leads to a strong decrease in inflammatory 
response, which is associated with a rise in plasma leptin. Also the amount of body 
fat increased which probably also contributed to the rise in leptin. These effects 
were more prominent in women. Zinc and vitamin A supplementation did not affect 
the leptin concentrations. The rise in leptin might be beneficial for the recovery of 
tuberculosis.  
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Chapter 7  
 
General discussion and avenues for future research 
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General discussion 
In the 2008 Copenhagen Consensus, the importance of zinc and vitamin A as 
low-cost nutritional supplementations was addressed and recommended to combat 
malnutrition, especially among children. In-vitro studies have proven that zinc and 
vitamin A improve the immune response. It has also been proven that low plasma 
zinc and vitamin A (in the form of retinol) may cause a decrease of the immune 
response and thus, increase the vulnerability and severity of the disease.(1),(2)  
In a study in Jakarta, low plasma zinc and retinol levels were very common 
among TB patients.(3) These findings raised the question as to whether 
supplementation of zinc and / or vitamin A will be beneficial when given to patients 
in conjunction with TB treatment. In a randomised controlled study in Jakarta, it 
was found that the combination of zinc and vitamin A, when given as a supplement 
to regular TB treatment, reduced the sputum conversion time and improved lung 
recovery.(4) Based on this finding, we conducted another study, presented in this 
thesis, in Nusa Tenggara Timur (NTT) Province, one of poor provinces in Indonesia, 
which has high prevalence of TB. The aim was to answer the question which of the 
two micronutrients was responsible for the effect of the previous finding in Jakarta. 
Before addressing that question, we studied malnutrition (in a broad sense) and 
socio-demographic factors in relation to TB (Chapter 2). In a baseline study 
reported in Chapter 3, we assessed zinc and vitamin A deficiency status, as well as 
macronutrient deficiency status, among TB patients, and its impact on the clinical 
presentation. In Chapter 4 we report about the intervention trial in which we 
compared the effect of vitamin A and zinc supplementation, either alone or in 
combination, versus placebo, given on top of regular TB treatment, on sputum 
conversion time. In addition we explored the mechanisms underlying the effect of 
micronutrient supplementation (reported in Chapters 5 and 6). 
Methodology  
In Chapter 2 and 3, we used a case-control design, to assess macro- and 
micronutrient deficiencies in relation to TB susceptibility and severity of TB. Using a 
four-arm randomized double-blind field trial design (Chapter 4), we studied the 
effect of micronutrient supplementation used in conjunction with TB treatment.  In 
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the trial, participants were randomised to four groups consisting of zinc, vitamin A, 
zinc + vitamin A supplementation groups versus placebo.  
The limitation of the case-control study was that macro- and micronutrient 
deficiencies may increase TB susceptibility and severity, but may also be the result 
of TB (chapter 2 and 3).  Therefore, in chapter 2 and 3, macronutrient and 
vitamin A deficiency were associated with severe TB, and not that these deficiencies 
were risks factors for TB and severe TB. For the latter, a long-term cohort study 
would have been required.  
The studies also have several strong points. In Chapter 2 by having three 
controls for each case among the non-TB neighbours, we could best describe 
factors associated with TB and the three controls strengthened the conclusion.  A 
four-arm double-blind randomization as performed in Chapter 4, minimizes 
observation bias, since the assessments of the patients are done without any 
knowledge of the different treatments. Yet, a field trial compared to a hospital-
based trial has strong and weak points.  In a hospital-based trial, factors that might 
influence the outcomes can be controlled better than in a field trial; for example: 
dietary intake, co-infections, and use of other medication. A field trial better 
represents the real-life situation with various environmental influences, so that the 
results can be better generalised.  
 
Interpretation of findings 
 
Plasma zinc and retinol in inflammation 
Low plasma concentrations of zinc and retinol among TB patients are 
frequently observed and interpreted as deficiencies. These low levels are used to 
justify supplementation of those micronutrients. One issue is how to interpret zinc 
and vitamin A deficiencies in the presence of inflammation caused by TB. The 
second issue is whether low plasma concentrations represent clinically significant 
deficiencies necessitating supplementation.    
An inflammatory process itself may cause low plasma zinc and retinol, thus 
deficiency cannot be concluded without considering the inflammation. It was 
suggested to classify deficiency based on C-reactive protein (CRP) concentrations, 
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as part of the acute phase protein response in inflammation. Among patients with 
non-elevated CRP, plasma zinc and retinol concentrations are classified as 
deficiency if the concentrations are below the cut-off points.  This classification was 
used in the first study of our group in Jakarta to prove that TB patients were 
severely deficient of zinc and vitamin A compared to healthy non-TB controls.(3) 
However, in this way misclassification might occur in TB patients with real 
deficiencies, and having elevated CRP due to concomitant other diseases or injuries. 
Alternatives are to use other markers, such as alpha1–acid-glycoprotein(5), retinol 
binding protein and zinc proto-porphyrine to measure the degree of inflammation 
and to determine zinc and vitamin A deficiency. Because of limited budget however, 
we could only measure CRP.  
Due to the limitations of CRP, in the study reported in Chapter 3, we did not 
classify zinc and vitamin A deficiencies based on CRP levels, rather, we used 
statistical modelling to measure the impact of zinc and vitamin A levels on the 
severity of TB (Karnofsky score (KS) > 80 mild TB; KS ≤ 80 severe TB) adjusted for 
CRP. We found that plasma retinol, but not zinc, concentrations, were associated 
with the severity of TB. Our findings are in line with a study in Malawi(6) which 
showed that vitamin A deficiency worsened the clinical and nutritional status of TB 
patients. Therefore, we strengthened the evidence that vitamin A deficiency may 
cause severe TB.  
In our cohort of TB patients studied in NTT Province, the prevalence of zinc 
and vitamin A deficiency may have been higher than in the TB patients studied in 
Jakarta. Despite lower median CRP concentrations (27.7 mg/L), the  plasma levels 
of zinc (11.9 µmol/L) and retinol (0.7  µmol/L) of our study groups (Chapter 3) 
were lower than in the Jakarta study (35mg/L for CRP, 12.4 µmol/L for zinc, 0.99 
µmol/L for retinol)(3). In the Jakarta study higher CRP concentrations correlated 
with lower zinc and vitamin A concentrations.  One possible explanation of these 
findings is that many of our TB patients in NTT might already been deficient in zinc 
and vitamin A before developing TB. This may explain why a similar dose of zinc 
and vitamin A supplementation had a different effect in our study in NTT compared 
to the previous study in Jakarta.  
 
 115 
Effect of zinc and vitamin A on sputum conversion time 
The primary outcome of the study reported in Chapter 4 was the reduction 
of sputum conversion time: the time from Acid Fast Bacilli (AFB) sputum smear 
positivity to negativity. The use of this outcome parameter was chosen following 
the National (Indonesian) TB Program. The length of observation for the conversion 
time was eight weeks, and most of the patients converted to negative after 8 weeks 
of treatment. Although we found significant difference in univariate analysis among 
the four groups, in the Cox regression model, supplementation of zinc and vitamin 
A – either single or in combination - failed to show significantly shorter conversion 
times compared to placebo. It is likely however, that sputum conversion times were 
actually different within the first month of treatment. In the Jakarta study (4), 
mean sputum conversion time was 3.9 weeks in the supplemented group, a week 
earlier than in the placebo group. In our study in NTT, there was a tendency to 
shorter conversion time after one month of treatment.  
Our results are in line with a study in Tanzania,(7) showing that zinc 
supplementation alone did not result in earlier sputum culture conversion compared 
with multi-micronutrient supplementation and placebo. It is also in line with the 
Singapore study which could not prove superiority of zinc supplementation over 
placebo to increase immune response. Likely, absence of zinc deficiency prior to 
treatment can explain why no beneficial effect was observed over placebo. It is 
possible that the absence of zinc deficiency in our study in NTT also was responsible 
for the negative outcome of the study, as mean zinc concentrations (11.9 µmol/L) 
were slightly higher than the cut-off value (10.7 µmol/L) for deficiency. The same 
might apply to plasma retinol concentrations, although the median plasma retinol 
concentration was at the border of deficiency (0.7 µmol/L). During TB treatment, 
recovery from inflammation may increase plasma zinc and retinol.   
Another possible explanation is that in our study in NTT we should have used 
higher micronutrient supplementation dosages than were used in the Jakarta study, 
as the mean concentrations of plasma zinc and retinol were lower in the population 
studied in NTT than in that studied in Jakarta.   
Another reason for the different results between NTT and Jakarta, may be 
that the TB patients in the study in NTT suffered from more severe TB than those in 
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Jakarta. This is witnessed by higher proportion of grade 3 sputum-smear positivity, 
lower nutritional status (mean BMI around 16 Kg/m2) and smaller active lesion 
areas in the chest x-ray at baseline in the NTT patients. The size of the active lesion 
areas, including the presence of cavities in the chest x-ray, reflects the immune 
response of the patients. In keeping with this, TB-HIV co-infected patients may 
have less pronounced abnormalities on chest x-ray.  
Finally, differences in ethnicities between the Jakarta and NTT populations 
may help explain the different findings in the two studies. One finding in our study 
was that ethnicity was associated with sputum conversion time. In line with this, a 
recent study showed that vitamin D receptor genetic polymorphisms were 
associated with the time to sputum culture conversion.(8) Also it was shown that 
vitamin D receptor genotype independently predicted the sputum smear conversion 
time while on anti-TB therapy.(9) One might speculate that ethnic background also 
plays a role in the response to supplementation with micronutrients. Further 
research in this area is needed. 
 
Effect of supplementation on other nutritional aspects 
We were not able to show a significant difference in terms of food intake 
between the supplementation groups and the placebo group. An external factor 
which is lack of food security in the study area, may contribute to the result. Lack 
of food may cause lower food intake and lower weight gain in NTT compared to 
Jakarta. It might also be possible that the patients already suffered from chronic 
protein and energy malnutrition (PEM) before the treatment was initiated. The pre-
existing PEM became worse because of the catabolic reaction of TB. Certainly, a 
chronic PEM cannot be corrected merely by zinc and vitamin A, it needs calorie and 
protein supplementation as well.   
 
Effect of supplementations on leptin and cytokine levels 
As part of our study in NTT Province, we examined leptin concentrations, in 
two groups: those receiving zinc + vitamin A supplementation and those receiving 
placebo (Chapter 6). We found that leptin concentrations, which were initially very 
low, increased during anti-TB treatment and the rise was much more pronounced 
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among female patients. Leptin levels rose while the inflammatory parameters (CRP) 
decreased. Contrary to our expectations, the rise in leptin did not correlate with the 
concentrations of zinc and / or retinol in plasma, and did not differ between the 
group receiving zinc + vitamin A supplementation and that receiving placebo.  
The explanation for this unexpected finding is probably that anti-TB 
treatment leads to a strong reduction in inflammatory response and this effect has 
an overriding impact on leptin regulation. This is in accordance with our finding of 
negative correlation of both log-transformed CRP level and log-transformed active 
lesion area on CXR, with leptin concentrations. The findings are in line with a study 
in Jakarta,(10) also reporting a negative correlation between CRP and log-
transformed leptin among TB patients in the course of treatment. Another 
explanation might be absence of zinc deficiency. Our study population was 
malnourished but two thirds of the patients did not exhibit true zinc deficiency.  
We showed that the amount of body fat correlates with leptin level at 
baseline, and after 2 and 6 months of treatment, particularly among women. The 
initial low leptin concentrations were most likely the result of low body fat and 
restoring body fat in response to TB treatment increased leptin concentrations. This 
is consistent with the findings in a longitudinal study by Schwenk et al.(11), 
showing significant increases in leptin levels and body fat after TB treatment. 
Another remarkable point was the more rapid weight gain in women during 
treatment. As woman‟s body composition consists of fat more than man, it is not 
surprising that woman produced more leptin than man in this study.   
In the earlier study of our group in Jakarta, it was found that zinc + vitamin 
A supplementation on top of anti-TB treatment promoted earlier sputum smear 
conversion and radiological resolution after two months of treatment.(4) As 
reported in Chapter 5, in the Jakarta study IL-6 was the only cytokine which was 
significantly lower in the micronutrient (zinc + vitamin A) supplementation group 
than in the placebo group. It was hypothesized that the level of IL-6 was reduced 
due to the micronutrient supplementation, which then would improve cell mediated 
immunity, thus decreasing inflammation. In our study in NTT Province, we were not 
able to replicate the previous finding in Jakarta. In fact, we found that among the 
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four groups the changes of IL-6 levels from baseline were not significantly different 
after finishing treatment. More likely, anti-TB treatment may have caused the 
decrease in IL-6 in these patients. The different results might be attributed to more 
severe condition of the NTT study patients. It could also be that the 
supplementations do not have their effect through this effector pathway. 
Last of all, one possible explanation for the different findings between Jakarta 
and NTT on the sputum conversion time as well as the immune response and leptin 
concentrations (Chapters 4, 5 and 6) might be the timing of the blood taking. We 
drew blood prior to, and after 2 and 6 month of treatment. All patients were getting 
better as the result of treatment after 2 and 6 months, but the largest difference in 
leptin and cytokine levels may have occurred in the first week up to first month, as 
was shown in the sputum conversion time.  
 
Implications for daily practice 
Low plasma zinc and vitamin A concentrations are common among TB 
patients and are mostly caused by the inflammatory process. To prove deficiency is 
rather difficult unless we measure other inflammatory markers. Low plasma retinol, 
but not low plasma zinc concentrations, contributed to the severity of TB. This 
study did not find supplementation of zinc and/or vitamin A to be effective in 
shortening sputum conversion time and improving immunity among newly 
diagnosed pulmonary TB patients. It is most likely that true deficiency cannot be 
proven and thus gave no effect. Also, severe malnutrition among the patients of the 
current study might contribute to the unexpected results. In such severely 
malnourished TB cases a higher dosage (>6000 IU daily) or additional protein 
supplementation might be needed and should be investigated in the future.  
Zinc supplementation (either alone or in combination with vitamin A) in the 
treatment of TB should not be pursued as routine procedure, as this study did not 
show clear benefits.   
 
Suggestions for future studies or implications for research 
Our studies raise the question whether both problems: macronutrient and 
micronutrient deficiency in patients with severe TB, should be addressed in 
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conjunction. Zinc and vitamin A supplementation alone might not have an impact 
when macronutrient deficiency is occurring at the same time, but when combined 
with interventions to combat macronutrient deficiency, this may be different. Future 
nutritional studies should therefore consist of four supplementation arms: zinc + 
vitamin A, zinc + vitamin A + protein, protein alone, and placebo.  
Since both in the Jakarta study and in our studies in NTT Province, the effects 
of supplementation on the conversion time were more pronounced in the first 
month of treatment, in order to capture the effects of supplementation on the 
cytokine response, it would be better to take samples during the first two months of 
the treatment on a weekly basis.    
 Because of the overriding effect of effective anti-mycobacterial therapy, it 
should be considered to perform a supplementation study in drug resistant TB.  
In view of the spread of HIV infection in Indonesia, and thus of an expected 
higher prevalence of TB and HIV co-infections, in future studies patients enrolled 
should be tested for HIV.   
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Summary 
Tuberculosis (TB) is one of the most prevalent infectious diseases in Indonesia 
(chapter 1). In the World Health Organization report 2008 Indonesia ranks number 
three in the world‟s prevalence of TB. The National Household Survey in 2004 
reported that the eastern Indonesian region had the highest prevalence of TB based 
on sputum acid fast bacilli (AFB) examination, confirmed by culture. TB is 
commonly associated with malnutrition, with macro- or micronutrient deficiency, or 
both. In our previous study in Jakarta, we demonstrated benefit of zinc + vitamin A 
supplementation in reducing sputum conversion time and in improving 
abnormalities on chest x-ray. In this thesis, further studies are reported to find out 
whether micronutrient supplementation, either single or in combination, contributes 
to the recovery from TB.    
In chapter 2, we identified nutritional and socio-demographic factors for 
development of TB in Timor and Rote Islands, East Nusa Tenggara province, 
Indonesia. We enrolled 101 newly diagnosed sputum smear-positive (SS+) 
pulmonary TB patients as cases, and 371 neighbours, matched for gender and age, 
as controls. Mean age was 30 years, 56.3% was male. Of the TB patients 87% had 
malnutrition compared to 33% among the controls. Mean body mass index (BMI) of 
the patients (16.1±2.3 kg/m2) was significantly lower than that of the controls 
(19.4±3.0 kg/m2). Factors associated with the development of TB were: BMI (OR: 
0.5; 95%CI: 0.4-0.6), family history of TB (OR: 3.2; 95%CI 1.6-6.4), living in an 
extended family (OR: 2.7, 95%CI: 1.5-4.8), being non-indigenous to Timor and 
Rote Islands (OR: 2.9; 95%CI 1.2-6.8), and being unemployed (OR: 3.8; 95%CI: 
1.7-8.6). We concluded that the prevalence of malnutrition among TB patients was 
very high, and that this problem should be addressed in the combat against TB. 
In chapter 3, we examined the association between micronutrient deficiencies and 
severity of TB. In a cross-sectional study, 300 newly diagnosed SS+ TB patients 
(63% male) in East Nusa Tenggara were categorized as either mild TB (Karnofsky 
Score - KS ≥ 80) or severe TB (KS < 80). BMI, mid upper arm circumference 
(MUAC), chest radiograph (CXR), and the results of haemoglobin, ESR, albumin, 
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CRP, zinc and vitamin A in plasma were correlated with TB category. Of the 300 
patients, 53% were categorized as mild TB and 47% as severe TB. Vitamin A, 
haemoglobin and plasma albumin were significantly lower, and CRP was 
significantly higher, in severe TB than in mild TB, and the active lesion area on the 
CXR was greater among severe TB patients. In multiple regression analysis, low 
vitamin A (β=3.2 95%CI 1.6-4.9, p=0.000), but not zinc, adjusted for CRP, 
correlated with the severity of TB. MUAC was better than BMI as predictor of TB 
severity (β=1.3 95%CI 0.6-6.2, p=0.000).  
Based on the above results and those from the previous study in Jakarta, we 
conducted a double blind randomized community trial among newly diagnosed 
pulmonary TB patients (chapter 4). TB patients were randomly assigned to receive 
either zinc, vitamin A, zinc + vitamin A, or placebo. Patients´sputum was examined 
weekly, and nutritional status, chest x-ray, haemoglobin, CRP, retinol and zinc 
level, were assessed prior to, after 2 months and 6 months of treatment. Initially, 
300 patients were enrolled, and 255 complied and finished the treatment. Most 
patients were severely malnourished (mean BMI 16.5 ±2.2 Kg/m2). There was no 
significant difference between the four arms in the Cox-regression model regarding 
sputum conversion time, although there was a tendency that in the first month 
sputum conversion was earlier among the zinc + vitamin A supplementation group 
(OR 1.4, 95%CI 0.9-2.0), but it was not sustained after two months. Also no 
benefit could be demonstrated of any of the used supplementations on other 
clinical, nutritional, chest x-ray, or laboratory findings. We could therefore not 
confirm that supplementation of zinc and vitamin A, either alone or in combination, 
significantly reduced sputum conversion time or had other benefit.  
In chapter 5, we studied the effects of zinc and vitamin A supplementation on 
cytokine levels during treatment of active pulmonary TB. We combined results from 
both study sites: Jakarta and Nusa Tenggara Timur (NTT). In the Jakarta group, 80 
eligible TB patients were assigned randomly to supplementation with zinc + vitamin 
A (40) or placebo (40), whereas in NTT 300 patients were included, given either 
zinc (76), vitamin A (72), zinc + vitamin A (66), or placebo (86). Standard TB 
treatment was given with daily supplementation until 6 months. No significant 
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difference of baseline characteristics between the subgroups in Jakarta and NTT 
was found. In the Jakarta study, after 2 months of treatment (but not after 6 
month), significant reductions of circulating IL-6 and ex-vivo LPS-stimulated IL-6 
between patients supplemented with zinc + vitamin A and those given placebo were 
found. The LPS-induced ex-vivo production of IL-1β, TNF-α and IL-1RA, which was 
elevated at baseline, significantly decreased during treatment but did not differ 
between both groups. PPD-induced IFNγ production increased over the treatment 
period, but again to the same extent in both groups.  In the NTT study, we 
measured only IL-6 since this cytokine decreased significantly in the zinc + vitamin 
A supplemented group in the Jakarta study. In all four groups we found a decrease 
of CRP, as well as of circulating IL-6 concentrations, after 2 and 6 months of 
treatment; however the rate of decrease did not differ between the groups. In 
conclusion, while combined zinc and vitamin A supplementation appeared to induce 
a stronger reduction of IL-6 concentrations in Jakarta compared with placebo, these 
findings could not be replicated in NTT.   
In chapter 6, we examined whether the increase of leptin during anti-TB 
treatment was correlated with zinc + vitamin A supplementation compared with 
placebo. At baseline, leptin concentrations in the zinc + vitamin A supplementation 
group (n=48) and the placebo group (n=50) were very low. These levels increased 
equally in both groups, to approximately twice the baseline level during anti-TB 
treatment. Women had higher leptin levels than men at baseline, and after 2 and 6 
month of treatment (p<0.000). Log-transformed leptin concentrations correlated 
inversely with CRP. There was also a correlation with the percentage of body fat, 
prominently among female patients at baseline, and after 2 and 6 months of 
treatment.  We concluded that the rise in leptin concentrations during anti-TB 
treatment correlates with the decrease in inflammation and with the increase of 
body fat. Supplementation with zinc + vitamin A did not affect leptin 
concentrations.  
 In chapter 7 our findings are discussed and put in perspective. TB patients 
had poor nutritional status and low vitamin A levels were associated with more 
severe tuberculosis. In East Nusa Tenggara (NTT) we could not confirm the 
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previous finding in Jakarta that vitamin A and zinc supplementation reduced 
sputum conversion time. This was mainly caused by the poor nutritional status of 
the TB patients in NTT when enrolled in the study. Certainly, the problem of 
macronutrient deficiency can not be solved by supplementation with the 
micronutrients zinc and vitamin A. On the other hand, anti-TB treatment may 
outweigh the effect of the micronutrient supplementation. It also may be that the 
dosage of the given micronutrients should be higher in severely malnourished TB 
patients.  
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Samenvatting 
Tuberculose (TB) is een van de meest voorkomende infectieziekten in Indonesië 
(hoofdstuk 1). In het WHO rapport uit 2008 neemt Indonesië de derde plaats in op 
de ranglijst van landen met een hoge prevalentie van TB. Het “National Household 
Survey” (Jakarta, 2004)  vermeldt dat het oosten van Indonesië de hoogste TB 
prevalentie heeft, dit op basis van Ziehl-Neelsen (ZN) onderzoek van het sputum, 
bevestigd door kweek. TB wordt in het algemeen geassocieerd met ondervoeding, 
dit op basis van deficiëntie van zowel macro-nutriënten als van micronutriënten. In 
ons eerdere onderzoek in Jakarta, werd aangetoond dat extra toediening van zinc + 
vitamine A tijdens behandeling van TB, de tijd verkortte tot het sputum ZN-negatief 
werd. Tevens hadden deze micronutriënten een gunstig effect op verbetering van 
de röntgenologische afwijkingen op de thoraxfoto. In dit proefschrift worden nadere 
studies gepresenteerd, die erop gericht waren vast te stellen of toediening van de 
micronutriënten zinc en vitamine A, ofwel ieder op zich of in combinatie, tijdens 
behandeling het herstel van TB bespoedigen. 
In hoofdstuk 2 wordt een onderzoek gerapporteerd naar voedingsfactoren en 
sociaal-demografische factoren die mogelijk geassocieerd zijn met TB op de 
eilanden Timor en Rote (delen van de provincie Oost Nusa Tenggara in Indonesië). 
We onderzochten 101 nieuw gediagnostiseerde sputum ZN-positieve patiënten met 
long-TB en 371 buren van de patiënten, gematcht voor geslacht en leeftijd, als 
controlepersonen. De gemiddelde leeftijd was 30 jaar en 56.3% waren mannen. 
Van de TB patiënten was 87% ondervoed en van de controlepersonen 33%. De 
gemiddelde “body mass index” (BMI) van de patiënten (16.1±2.3 kg/m2) was 
significant lager dan die van de controlepersonen (19.4±3.0 kg/m2). Factoren 
geassocieerd met de ontwikkeling van TB waren: BMI (OR: 0.5; 95%CI: 0.4-0.6), 
het voorkomen van TB in de familie (OR: 3.2; 95%CI 1.6-6.4), deel uitmaken van 
een “extended family” (OR: 2.7, 95%CI: 1.5-4.8), behoren tot de niet-
oorspronkelijke bevolking van Timor en Rote (OR: 2.9; 95%CI 1.2-6.8), en 
werkeloosheid (OR: 3.8; 95%CI: 1.7-8.6). Onze conclusie was dat de prevalentie 
van ondervoeding onder TB patiënten op deze eilanden zeer hoog is. Dit probleem 
dient aangepakt te worden bij de bestrijding van TB. 
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In hoofdstuk 3, werd de associatie onderzocht tussen tekort aan micronutriënten en 
de ernst van TB. In een dwarsdoorsnede-onderzoek werden 300 nieuw 
gediagnostiseerde sputum ZN-positieve TB patiënten (63% mannen) in East Nusa 
Tenggara gecategoriseerd als milde TB (Karnofsky Score - KS ≥ 80) of ernstige TB 
(KS < 80). BMI, “mid upper arm circumference” (MUAC), röntgenfoto van de thorax 
(X-thorax), en de bloedwaarden van haemoglobine, bezinking, albumine, CRP, zinc 
en vitamine A in plasma werden gecorreleerd met de TB categorie. Van de 300 
patiënten had 53% milde TB en 47% ernstige TB. Vitamine A, haemoglobine en 
albumine waren significant lager, en CRP significant hoger bij ernstige TB dan bij 
milde TB. Ook was het gebied op de X-thorax met actieve afwijkingen groter bij 
patiënten met ernstige TB. In de multipele regressie-analyse, was een lage waarde 
van vitamin A in plasma (β=3.2 95%CI 1.6-4.9, p=0.000), gecorrigeerd voor de 
hoogte van het CRP, gecorreleerd met de ernst van de TB. Deze correlatie was er 
niet met de waarde van zinc in plasma. MUAC had een betere voorspellende waarde 
dan BMI voor de ernst van TB (β=1.3 95%CI 0.6-6.2, p=0.000).  
Op basis van bovengenoemde resultaten en die van het eerdere onderzoek in 
Jakarta door Karyadi en medewerkers (2001), deden wij een dubbel-blind 
interventieonderzoek onder nieuw gediagnostiseerde sputum ZN-positieve TB 
patiënten (hoofdstuk 4). De TB patiënten werden willekeurig toegewezen om een 
van de volgende supplementen te ontvangen: zinc, vitamine A, zinc + vitamine A, 
of een placebo. Elke week werden ZN preparaten van het sputum onderzocht. 
Tevens werden vóór het begin van de TB behandeling, alsook 2 maanden en 6 
maanden na het begin van de behandeling, de volgende gegevens verzameld: 
voedingstoestand, X-thorax, haemoglobinegehalte, CRP, en de plasmaconcentraties 
van retinol en zinc. Van de 300 patiënten die aanvankelijk in de studie werden 
opgenomen, maakten 255 het onderzoek af. De meeste patiënten waren ernstig 
ondervoed (gemiddelde BMI 16.5 ±2.2 Kg/m2). Het aantal weken vanaf het begin 
van de TB behandeling totdat het sputum ZN-negatief werd (sputum-conversie) 
verschilde niet significant tussen de vier interventiegroepen in het Cox-
regressiemodel, ofschoon er wel een tendens was dat de sputum-conversie eerder 
optrad bij degenen die zinc + vitamine A als supplement hadden gekregen (OR 1.4, 
95%CI 0.9-2.0). Na de eerste 2 maanden was dat verschil echter verdwenen. Ook 
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konden wij geen gunstig effect aantonen van de gebruikte voedingssupplementen 
op klinische parameters tijdens de behandeling, noch op de voedingstoestand, de 
X-thorax, of uitslagen van laboratoriumonderzoek. We konden daarom de 
uitkomsten van het onderzoek in Jakarta niet bevestigen dat toediening van zinc en 
vitamine A, elk apart of gecombineerd, als supplement bij de TB behandeling, de 
sputum-conversie bespoedigde of anderszins voordelen opleverde voor de patiënt.  
In hoofdstuk 5, bestudeerden wij het effect van zinc en vitamine A suppletie op de 
cytokine waarden tijdens behandeling van actieve long-TB. We combineerden de 
resultaten van twee studies: de eerdere studie in Jakarta (Karyadi, 2001) en onze 
eigen studie in Nusa Tenggara Timur (NTT). In de Jakarta studie werden 80 TB 
patiënten opgenomen, die willekeurig toegewezen werden om ofwel zinc + vitamine 
A als voedingssupplement te krijgen (40 patiënten) of placebo (40). In de studie in 
NTT werden 300 patiënten opgenomen. Deze kregen een van de volgende vier 
supplementen: zinc (76 patiënten), vitamine A (72), zinc + vitamine A (66), of 
placebo (86). Alle patiënten kregen standaard TB behandeling en daar bovenop het 
betreffende voedingssupplement gedurende 6 maanden. De beginwaarden van alle 
parameters vertoonden geen significante verschillen, noch in Jakarta, noch in NTT. 
Bij het onderzoek in Jakarta, waren 2 maanden na het begin van de behandeling 
(maar niet meer na 6 maanden), de concentraties van IL-6 in de circulatie, alsook 
die van IL-6 na ex-vivo stimulatie met LPS, bij de patiënten gesupplementeerd met 
zinc + vitamin A significant lager dan de waarden bij patiënten die placebo hadden 
gekregen. De met LPS gestimuleerde ex-vivo producties van IL-1β, TNF-α en IL-
1RA, die verhoogd waren voor de start van de behandeling, daalden significant 
tijdens behandeling, maar zonder verschil tussen de verschillende 
suppletiegroepen. De door PPD gestimuleerde ex-vivo productie van IFNγ steeg 
tijdens de behandeling, maar ook hier was er geen verschil tussen de verschillende 
groepen. Bij de studie in NTT, besloten wij alleen IL-6 te meten omdat bij dit 
cytokine in Jakarta een significante daling was gevonden in de zinc + vitamine A 
supplementatiegroep  t.o.v. placebo. In alle vier suppletiegroepen daalde het CRP, 
evenals de concentratie van IL-6 in de circulatie na 2 en 6 maanden TB 
behandeling. Echter de mate van daling verschilde niet tussen de vier groepen. 
Ofschoon dus in Jakarta de combinatie van zinc en vitamine A een sterkere daling 
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van de IL-6 concentratie bewerkstelligde dan placebo, konden wij deze bevindingen 
niet bevestigen in NTT. 
In hoofdstuk 6 wordt een onderzoek gerapporteerd naar de vraag of de 
toename van leptine tijdens TB behandeling is gecorreleerd aan supplementatie 
met zinc + vitamine A, dit in vergelijking met placebo. De uitgangsconcentraties 
van leptine bij de patiënten die zinc + vitamin A supplement kregen (n=48) 
verschilden niet significant van diegenen die placebo kregen (n=50), en waren erg 
laag. Tijdens de TB behandeling steeg leptine tot vergelijkbare concentraties in 
beide groepen, en wel tot ongeveer het dubbele van de uitgangswaarde. Vrouwen 
hadden hogere waarden van leptine dan mannen, zowel vóór de start van 
behandeling, als na 2 en 6 maanden behandeling (p<0.000). De log-
getransformeerde leptine concentraties waren negatief gecorreleerd met de waarde 
van CRP. Er werd ook een correlatie gevonden tussen leptine en het percentage 
lichaamsvet, met name bij vrouwen, zowel vóór behandeling, als na 2 en 6 
maanden TB behandeling.  De conclusie was dat de stijging van de leptine 
concentraties tijdens TB behandeling gecorreleerd was met een afname van de 
mate van ontsteking en met een toename van het lichaamsvet. Echter, toediening 
van zinc + vitamine A als voedingssupplement had geen invloed op de leptine 
concentraties.  
 In hoofdstuk 7 worden onze bevindingen besproken en in perspectief 
geplaatst. De bestudeerde TB patiënten hadden een slechte voedingstoestand en 
lage vitamine A waarden waren geassocieerd met ernstige tuberculose. In Oost 
Nusa Tenggara (NTT) konden wij de eerdere bevindingen in Jakarta niet bevestigen 
dat toediening van vitamine A en zinc als voedingssupplement de sputum-conversie 
van ZN-positief naar ZN-negatief verkortte. Dit werd waarschijnlijk veroorzaakt 
door de slechte voedingstoestand van de patiënten in NTT bij opname in het 
onderzoek. Het is duidelijk dat een deficiëntie van macronutriënten niet kan worden 
behandeld door toediening van micronutriënten zoals zinc en vitamine A. Het zou 
ook kunnen dat het effect van de TB behandeling groter is dan dat van de gegeven 
voedingssupplementen. Wellicht had de dosis van de gegeven micronutriënten 
hoger moeten zijn bij dergelijke ernstig ondervoedde TB patiënten.  
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Ringkasan 
Tuberkulosis (TB) adalah salah satu penyakit menular yang tinggi prevalensinya di 
Indonesia. Menurut World Health Organization tahun 2008, Indonesia masih 
merupakan negara nomor tiga terbesar dengan prevalensi TB di dunia. Survey 
Kesehatan Rumah Tangga 2004, melaporkan wilayah Indonesia Timur merupakan 
daerah dengan prevalensi TB tertinggi yang dibuktikan dengan pemeriksaan BTA 
(Basil Tahan Asam) di dahak,dahak dan dikonfirmasi melalui pemeriksaan kultur 
dahakkultur. TB seringkali ditemukan bersamaan dengan kondisi malnutrisi, yaitu 
defisiensi gizi makro dan mikro. Pada penelitian awal di Jakarta mendapatkan 
bahwa suplementasi seng+vitamin A dapat mempercepatmereduksi lebih awal 
waktu konversi sputum dan meningkatkan penyembuhan paru yang dinilai 
dariberdasarkan pemeriksaan foto sinar-X.radiologi dada. Penelitian kali ini 
merupakan kelanjutan studi yang di Jakarta untuk mengetahui apakah salah satu 
dari mikronutrien zat gizi mikro atau kombinasi keduanya berpengaruh terhadap 
penyembuhan TB.  
Dalam bab 2, kami mengidentifikasi faktor-faktor gizi dan sosio-demografik 
yang mempengaruhi terjadinya TB di pulau Timor dan Rote. Sebagai kasus adalah 
TB paru dengan pemeriksaan BTA (bakteri tahan asam) positif dan sebagai 
kontrolnya adalah tetangga sekitar pasien yang sama umur dan jenis kelamin. 
Seratus satu pasien TB dengan 371 kontrol berpartisipasi di dalam studi ini. Rata-
rata umur responden 30 tahun, 56.3% adalah laki-laki dan 47.3% adalah 
perempuan. Sebanyak 87% pasien TB menderita malnutrisi dibandingkan control 
33%. Rerata indeks masa tubuh (IMT) pasien (16.1±2.3 Kg/m2) lebih rendah 
signifikan dibandingkan dengan control (19.4± 3.0 Kg/m2). Faktor-faktor yang 
berasosiasi dengan terjadinya TB adalah: IMT (OR 0.5;95% CI 0.4-0.6), riwayat 
keluarga dengan TB (OR 3.2; 95%CI 1.6-6.4), tinggal dalam keluarga majemuk 
(OR 2.7; 95% CI 1.5-4.8), bukan penduduk asli Timor atau Rote (OR 2.9; 95% CI 
1.2-6.8) , dan tidak bekerja (OR 3.8; 95% CI 1.7-8.6). Kami menyimpulkan bahwa 
prevalensi malnutrisi diantara pasien TB sangat tinggi, ini juga merupakan masalah 
umum di masyarakat, dan khususnya penting bagai para pendatang ke Timor dan 
atau Rote. Masalah malnutrisi harus menjadi perhatian dalam menanggulangi TB.  
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Dalam bab 3, kami memeriksa apakah ada asosiasi antara defisiensi zat gizi 
mikro dengan tingkat keparahan TB. Dengan studi potong-lintang, pasien TB paru 
BTA + kasus baru di Nusa Tenggara Timur (NTT) digolongkan sebagai TB ringan 
(skor Karnofsky≥ 80) dan TB berat bila SK < 80. Kami mengukur IMT, lingkar 
lengan atas (LiLA), foto rontgen dada, dan pemeriksaan darah lainnya seperti 
hemoglobin, laju endap darah, albumin, C-reactive protein (CRP), plasma seng dan 
vitamin A. Semua faktor dikorelasikan dengan kategori TB. Tiga ratus pasien 
berpartisipasi dalam penelitian ini (63% laki-laki dan 37% perempuan), 
dikelompokkan sebagai TB ringan (53%) dan TB berat (47%). Vitamin A, 
hemoglobin dan albumin plasma pada pasien TB berat lebih rendah secara 
bermakna dibandingkan dengan pada pasien TB ringan. CRP lebih tinggi secara 
bermakna, sedangkan lesi aktif foto rontgen  lebih luas pada pasien TB berat 
dibandingkan dengan yang ringan. Dalam uji ‘multiple regressions (regresi 
multipel)‟ , kadar vitamin A (β=3.2 95%CI 1.6-4.9, p=0.000) yang rendah - dan 
bukan zinc -  berdasarkan konsentrasi plasma CRP, berkorelasi dengan tingkat 
keparahan TB. LILA merupakan alat ukur yang lebih baik daripada BMI untuk 
memprediksi tingkat keparahan TB (β=1.3 95%CI 0.6-6.2, p=0.000). 
 Berdasarkan hasil-hasil penelitian di atas dan juga penemuan sebelumnya di 
Jakarta, kami memberikan suplementasi kepada pasien-pasien TB paru tersebut 
dan hasilnya dijabarkan dalam bab 4. Dengan desain penelitian „Buta acak ganda, 
pasien-pasien TB dikelompokkan secara acak untuk menerima suplementasi seng, 
vitamin A, kombinasi seng+vitamin A, atau plasebo. Pasien-pasien diminta 
mengantarkan sputum setiap minggu dan diperiksa status gizi, foto rontgen dada, 
Hb, CRP, kadar retinol dan seng pada waktu awal pengobatan, akhir bulan ke-2 dan 
ke-6 setelah pengobatan. Pada mulanya, 300 pasien berpartisipasi dan tinggal 255 
orang yang menyelesaikan pengobatan. Hampir semua pasien mengalami malgizi 
berat (rerata IMT 16.5±2.2 Kg/m2). Tidak ada perbedaan yang bermakna dari 
semua kelompok perlakuan dalam model Cox-regression. Ditemukan adanya 
kecenderungan konversi sputum terjadi lebih cepat pada kelompok yang menerima 
seng+vitamin A (OR 1.4;95% CI 0.9-2.0) pada bulan pertama, tetapi hasil ini tidak 
sama pada akhir bulan ke-2. Juga tidak ditemukan manfaat suplementasi baik pada 
status kesehatan, status gizi, foto rontgen, atau hasil-hasil laboratorium lainnya. 
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Sebagai kesimpulan, kami tidak dapat mengkonfirmasi hasil penelitian di Jakarta 
bahwa suplementasi seng dan vitamin A dapat mereduksi waktu konversi sputum, 
atau adanya keuntungan lain.  
 Dalam bab 5, kami mempelajari pengaruh suplementasi seng dan vitamin A 
pada konsentrasi sitokin selama pengobatan TB berlangsung. Kami 
menggabungkan penelitian yang dilakukan di kedua tempat, Jakarta dan NTT. 
Pasien TB paru di Jakarta dibagi dua secara acak untuk mendapatkan suplementasi 
kombinasi seng + vitamin A dan plasebo, sedangkan di NTT dibagi dalam 4 
kelompok yang menerima seng, vitamin A, kombinasi serta plasebo. Pengobatan 
standar TB diberikan bersama dengan suplementasi selama 6 bulan setiap hari. 
Delapan puluh pasien berpartisipasi dalam penelitian di Jakarta dibagi dua sama 
besar, sedangkan di NTT terdapat 300 pasien yang dibagi menjadi group seng (76), 
group vitamin A (72), group seng+vitamin A (66), dan group plasebo (86). Tidak 
ada perbedaan bermakna dalam karakteristik dasar pasien di setiap kelompok, baik 
di Jakarta maupun di NTT. Setelah dua bulan pengobatan (dan tidak pada enam 
bulan), terdapat penurunan bermakna pada kadar interleukin-6 (IL-6), baik yang di 
dalam plasma (sirkulasi) maupun yang distimulasi dengan LPS ex-vivo, pada 
pasien-pasien yang menerima seng+vitamin A  dibandingkan dengan plasebo di 
Jakarta. Produksi IL-1β, TNF-α and IL-1RA ex-vivo dengan induksi LPS, meningkat 
pada awal penelitian,dan menurun secara bermakna selama pengobatan, tetapi 
tidak ada perbedaan di antara kedua Kelompok perlakuan. Produksi IFN-γ yang 
diinduksi PPD meningkat selama pengobatan, tetapi tidak ada perbedaan diantara 
kedua kelompok. Untuk penelitian di NTT, kami memutuskan untuk memeriksa 
kadar IL-6 saja karena sitokin ini yang menurun secara bermakna. Kami 
menemukan bahwa kadar CRP dan juga IL-6 menurun tajam setelah bulan ke-2 
dan 6; tetapi penurunan tersebut tidak berbeda diantara kelompok-kelompok 
perlakuan. Jadi di kedua penelitian ini, pengobatan TB berpengaruh lebih kuat 
untuk menurunkan sitokin penanda inflamasi. Kombinasi seng dan vitamin A 
terlihat mereduksi IL-6 lebih kuat dibandingkan placebo pada penelitian di Jakarta, 
tetapi hasil ini tidak tampak pada penelitian di NTT.  
 134 
 Dalam bab 6, kami mengukur peningkatan leptin dikaitkan dengan 
suplementasi seng+vitamin A. Pada kondisi awal, konsentrasi leptin dalam 
kelompok suplementati seng+ vitamin A (n=48) dibandingkan dengan placebo 
(n=50) sangat rendah. Kadar leptin tersebut meningkat bersamaan di kedua 
kelompok sampai mencapai kira-kira dua kalinya selama pengobatan TB. Wanita 
memiliki kadar leptin yang lebih tinggi daripada laki-laki pada kondisi awal, setelah 
bulan ke-2 dan ke-6 (p<0,000). Transformasi logaritmik konsentrasi leptin 
berkorelasi terbalik dengan kadar CRP. Juga, terdapat korelasi antara persentasi 
lemak tubuh, terutama pada wanita saat awal, setelah bulan ke-2 dan ke-6 
pengobatan.  Kami menyimpulkan bahwa konsentrasi leptin selama pengobatan TB 
berkorelasi dengan penurunan inflamasi dan dengan peningkatan persentase lemak 
tubuh. Suplementasi seng+ vitamin A tidak mempengaruhi konsentrasi leptin.  
 Secara umum dapat disimpulkan bahwa pasien-pasien TB memiliki status gizi 
yang buruk dan bahwa kadar vitamin A yang rendah di dalam plasma berasosiasi 
dengan tingkat keparahan TB. Penelitian ini tidak dapat mengkonfirmasi penemuan 
penelitian sebelumnya di Jakarta terutama disebabkan karena status gizi yang lebih 
buruk pada pasien-pasien NTT  pada saat berpartisipasi di dalam penelitian. Tentu 
saja, masalah kekurangan gizi makro tidak dapat diselesaikan hanya dengan 
pemberian gizi  mikro, seperti  seng dan vitamin A.   Di sisi lain, efek pemberian 
obat anti tuberkulosis menutupi efek suplementasi. Penelitian ini dapat menjadi 
dasar untuk mempertimbangkan pemberian dosis suplemen yang sebaiknya lebih 
tinggi pada pasien-pasien TB dengan status gizi buruk.   
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